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GENERAL INTRODUCTION 
Vitamin A has been the subject of study for many years. 
The necessity of vitamin A for growth, vision, reproduction, 
and maintenance of healthy epithelium has been well 
documented. Early research also reported a role of vitamin A 
as an anti-infective agent. This role of vitamin A recently 
has begun to receive a great deal more attention. Studies 
have reported the harmful effects of vitamin A deficiency on 
immune function in many species. Dairy cattle may be 
especially susceptible to alterations in vitamin A status 
because of a documented decline in plasma vitamin A during the 
periparturient period. The question addressed in the present 
studies is whether administration of vitamin A above 
requirements may affect immune function and possibly provide 
additional protection for dairy cattle. 
Dissertation Format 
This dissertation includes three manuscripts that will be 
submitted to the Journal of Dairy Science. Paper I is 
coauthored by B. J. Nonnecke and J. W. Young and provides 
background information important for interpretation of results 
obtained in Paper III; Paper II is coauthored by B. J. 
Nonnecke, R. L. Horst, and J. W. Young; and Paper III is 
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coauthored by B. J. Nonnecke and J. W. Young. A 
representative review of the literature precedes the first 
manuscript and covers vitamin A metabolism and the effects of 
vitamin A on immune function. A general summary follows the 
three manuscripts. Literature cited in the general 
introduction, literature review, and general summary follow 
the general summary. 
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LITERATURE REVIEW 
Vitamin A 
Introduction 
In 1913, McCollum and Davis (107) reported that certain 
lipins were required in the diet to support the growth of 
rats. The phrase "vitamin A" had not yet been coined, but one 
of its functions had been determined already. Vitamin A has 
become a subject of intense study, and, for approximately 80 
years, researchers have worked to unravel its importance to 
animals. 
Beginning with the report by McCollum and Davis (107) and 
continuing through recent discoveries of nuclear retinoic acid 
receptors (RAR) and retinoic acid response elements (RARE), 
vitamin A has fascinated scientists because of its wide range 
of functions and its multiple active metabolites. Vitamin A 
functions in vision, growth and development, bone formation, 
reproduction, maintenance of healthy epithelium, and immune 
function. The literature review in this dissertation will 
provide an overview of important research concerning vitamin 
A. It will focus first on metabolism of vitamin A and then on 
the importance of vitamin A in immune function. 
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Early Research 
McCollum and Davis (107) noted that when young rats were 
fed diets containing only purified proteins, carbohydrates, 
fats, and salts, their growth was normal for approximately 
eight weeks, but eventually growth stopped. Growth resumed 
only when ether-soluble extracts from eggs or butter were 
added to the diet. Their conclusion was that the extracts 
contained some "organic complex" or "accessory articles" that 
were required for normal growth. McCollum is credited with 
proposing the name "fat-soluble A" for these growth promoting 
substances in eggs and butter. 
Mori in 1922 (109) reported effects of feeding diets 
deficient in fat-soluble A on certain glands and on the mucosa 
of the larynx and trachea. He noted that secretions were 
greatly decreased and that the epithelium became thickened 
with a high degree of cornification and desquamation. He also 
reported sterility in rats associated with dysfunction of 
their reproductive glands. In addition, the majority rats not 
sacrificed died of pneumonia. Mori reasoned that bacterial 
numbers probably were increased in the air passages, similar 
to increased bacterial numbers found in conjunctival sacs of 
rats with xerophthalmia. 
Bloch in 1924 (14) reported an increased incidence of 
xerophthalmia in Danish children from 1909 through 1917. He 
noted that xerophthalmia was preceded by cessation of growth, 
followed by a loss of weight. The children also often 
developed an infectious disease associated with the mucous 
membranes that was persistent and often fatal. He attributed 
the complex of problems to the absence of fresh milk, cream, 
or butter in diets of the children because these items were 
too expensive for poorer populations to purchase during World 
War I. In 1918, Denmark was under blockade, and dairy 
products could not be exported. Children again had access to 
butter, which resulted in a drastic decline in the incidence 
of xerophthalmia. Bloch noted that infections were gradually 
overcome, and he attributed this effect to fat-soluble A. He 
stated that this was "... in harmony with the old clinical 
experience that chronic infectious diseases, particularly 
tuberculosis, are improved by a diet rich in fresh milk, 
butter, and cod liver oil" (14, p. 46). 
Wolbach and Howe in 1925 (180) published a study of 
tissue changes associated with deprivation of fat-soluble A 
vitamin. They found that normal epithelium was replaced by 
stratified keratinizing epithelium in the respiratory tract, 
alimentary tract, eyes and paraocular glands, and the 
genitourinary tract. Replacement was a result of 
proliferation of cells arising from the original epithelium 
rather than changes involving preexisting cells. In deficient 
male rats, edema and subsequent atrophy of the testes 
occurred. They also examined tissues of the immune system and 
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reported atrophy of the spleen as the deficiency progressed. 
The secondary follicles in the spleen disappeared, and numbers 
of lymphoid cells decreased. The thymus was extremely smaller 
in deficient rats because of an almost complete loss of small 
thymic cells. Even though there were several changes in 
lymphoid tissues, no attempt was made to study resistance to 
infection. In summary, Wolbach and Howe concluded that 
alterations in the epithelium were not secondary to infection 
but were "a primary effect of the withdrawal of factors 
essential for the ... maintenance of differentiation of the 
epitheliums concerned." (180, p. 776) 
In contrast, Green and Mellanby (61) proposed that the 
term "anti-infective" be used to describe vitamin A. They fed 
rats diets deficient in vitamin A, but supplemented with 
vitamin D, to distinguish between effects of nutrient 
deficiency attributable to vitamin A from those attributable 
to vitamin D. Of the 93 rats on the vitamin A-deficient diet, 
only two gave no evidence of infection, whereas none of the 
control rats had evidence of gross infection. The authors 
suggested that increased susceptibility to infection might be 
the result of alterations of the epithelium alone or in 
conjunction with diminished immune resistance. Based on Green 
and Mellanby's research, five women with postpartum uterine 
infections were treated with high levels of vitamin A (108). 
In all cases, the infections had become systemic, as evidenced 
by the presence of Streptococcus haemolyticus in the blood, 
but all five patients recovered after treatment. The authors 
concluded that vitamin A was "possibly essential for the 
natural defense of the body against infective agencies" (108, 
p. 986). They recommended that "especially in times of 
special stress, as in pregnancy," (108, p. 986) the diet 
should contain a large supply of foods containing vitamin A. 
Green and Mellanby (62) also investigated whether 
carotene had anti-infective properties similar to vitamin A. 
In experiments designed to investigate both prophylactic 
effects and curative actions of carotene in rats, they found 
that .005 mg of carotene daily was sufficient to restore 
growth, but better resistance to infection was afforded by .02 
mg of carotene daily. In addition, analysis of livers from 
rats fed carotene indicated that carotene was stored in the 
liver as vitamin A, and might be responsible for the vitamin A 
activity supplied by carrots, green vegetables, and butter. 
Lassen in 1930 (92) evaluated effects of vitamin A 
deficiency on infection with a specific pathogen, Breslau 
bacillus. Rats were fed either a control or a vitamin A 
deficient diet. When the rats fed the deficient diet 
developed xerophthalmic conditions, all rats were infected 
with Breslau bacillus. In each of three experiments with 
different doses of bacteria and different modes of infection, 
19 of 22 deficient rats died as a result of infection whereas 
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only 2 of 20 control rats died. These results indicate an 
increased susceptibility to infection resulting from vitamin A 
deficiency. Unfortunately, no mention was made of food 
consumption in these experiments, and there were no pair-fed 
controls to determine if malnutrition occurred as a result of 
decreased feed intake apart from the vitamin A deficiency. 
The weight of vitamin A-deficient rats was approximately half 
that of the control rats and general malnutrition cannot be 
ruled out as a factor in the decreased survivability of the 
vitamin A deficient rats. 
In a 1942 review of vitamin A, Wolbach and Bessey (179), 
recognized the negative effects of vitamin A deficiency on 
hematopoietic tissues, but suggested there was no proof that 
these effects were different than those seen in other vitamin 
deficiencies. They considered changes in the epithelium to be 
the most characteristic feature of vitamin A deficiency and 
described these changes in detail. The results of vitamin A 
deficiency were the same in epithelia with many varied 
functions and locations. When animals were supplemented with 
vitamin A, the epithelia would return to its original function 
and morphology without undergoing division. 
Studies were conducted to determine if vitamin A 
deficiency inhibited responses to specific antigens (126, 
138). In one experiment (138), rats maintained on a vitamin 
A-deficient diet were immunized with diptheria toxoid, and 
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antibody titres were measured. Rats fed the vitamin A-
deficient diet exhibited an impaired antibody response 
compared to controls even though they were fed the 
experimental diets for only 12 days. This length of time 
should not have been long enough to deplete liver stores of 
vitamin A. No mention was made of feed consumption, and there 
was not a pair-fed group, so it cannot be ruled out that 
general malnutrition contributed to impaired antibody 
production. In a study on effects of suboptimal vitamin A 
content in diets for chickens, vitamin A deficiency resulted 
in decreased antibody production to Salmonella pullorum 
antigen and lower Bursa weights even though there was no 
difference in chick weights or feed to gain ratios (126). 
Both studies concluded that the vitamin A requirement for 
optimal antibody production was greater than the requirement 
for normal growth. 
By the mid 1950s, the role of the aldehyde form of 
vitamin A in vision had been elucidated by George Wald's 
group, but researchers knew this was not the only function of 
vitamin A. Wald studied tissue functions of vitamin A by 
investigating the effects of vitamin A acid in rats (44). 
Rats fed the diet containing vitamin A acid developed night 
blindness, and their stores of vitamin A in liver were 
depleted, even though they grew normally. Vitamin A acid was 
not stored in liver, kidney, or blood of the animals. 
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Therefore, when vitamin A acid was removed from the diet, the 
rats soon ceased to grow and died within 3 to 5 weeks. 
Because all functions investigated, except the visual process, 
could be supported by vitamin A acid, it was concluded that 
rats were unable to reduce the acid to the aldehyde or alcohol 
form and that the most important function of vitamin A was "as 
the storable precursor of vitamin A acid". 
Early research had demonstrated that vitamin A was 
essential in vision, growth, reproduction, maintenance of 
epithelium, bone formation, and immune function. Evidence 
that carotene was stored in the liver as vitamin A established 
an association between carotene and vitamin A. In addition, 
although vitamin A acid could support growth, it could not 
prevent night blindness. There also were suggestions that 
requirements of vitamin A or carotene to support immune 
function were greater than requirements to support growth. By 
1960, research began to focus on the metabolism of vitamin A. 
Metabolism of Vitamin A 
Introduction 
It was established that carotene was a precursor for 
vitamin A by 1930 (62). The structure of B-carotene had been 
determined and similarities between it and vitamin A became 
evident when the structure of retinol, the major form of 
vitamin A, was reported in 1931 (144). 
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vitamin A is present in animal tissues and products as 
retinyl esters, but retinyl esters are not present in plant 
materials. The only sources of vitamin A activity in plant 
materials are the carotenoids. There are nearly 600 
carotenoid compounds in nature, and approximately 50 of these 
possess vitamin A activity. All-trans beta-carotene is the 
most important vitamin A precursor among the carotenoids 
(118). The two other major carotenoids with provitamin A 
activity are 6-cryptoxanthin and a-carotene. In general, only 
carotenoids with one or more intact fl-ionone rings exhibit 
provitamin A activity. 
Several compounds that exhibit some or all of the 
biological activity of all-trans-retinol are included in the 
vitamin A group (119). The most important members, other than 
retinol, are retinal (retinaldehyde) and retinoic acid (RA). 
The vitamin A group belongs to a larger group of structurally 
related compounds, known as retinoids, which may or may not 
have all-trans-retinol activity and may be natural or 
synthetic analogs of retinol (119). This literature review 
will concentrate on the vitamin A group. 
Absorption 
Both vitamin A and B-carotene are lipld-soluble 
substances that require normal fat digestion and absorption to 
be absorbed. Vitamin A and B-carotene are released from 
r 
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dietary proteins by pepsin in the stomach and proteolytic 
enzymes in the small intestine (119). Beta-carotene and 
retinyl esters are solubilized by bile in the intestinal lumen 
and incorporated into micelles (72). Micelles carry R-
carotene and retinyl esters through the unstirred water layer 
to microvilli of enterocytes for absorption (72, 119). 
Absorption occurs mainly in the upper half of the small 
intestine (119). 
Dietary retinyl esters are hydrolyzed in the intestinal 
lumen by nonspecific pancreatic lipase (cholesterol esterase). 
The retinol, at physiological concentrations, then is absorbed 
by facilitated diffusion into enterocytes (17, 72). At 
pharmacological amounts, retinol Is absorbed by passive 
diffusion (17, 72). The amount of retinol absorbed has been 
reported to range from approximately 21% (17) to 75% (18). 
Although little RA is likely to be present In animal diets, 
studies suggest that dietary RA is absorbed from micelles 
mainly through the portal vein (46). Dietary retlnoic acid or 
retinoic acid formed in the enterocytes is absorbed directly 
into the circulatory system and circulates bound to serum 
albumin. 
Beta-carotene is absorbed by passive diffusion Into 
enterocytes (17, 72), but absorption decreases as the 
concentration of dietary fi-carotene Increases (17). This 
decrease may be a result of decreased digestion of plant 
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material rather than decreased absorptive ability (17). In 
humans, cattle, horses, and ferrets, a portion of B-carotene 
absorbed into intestinal mucosal cells is packaged intact into 
low-density lipoproteins (LDL) or high-density lipoproteins 
(HDL) and exocytosed into the lymphatics, which results in 
significant concentrations of plasma 6-carotene. The rest of 
the B-carotene absorbed by these species, as well as 
practically all B-carotene absorbed by rats, pigs, sheep, 
goats, and dogs, is converted to retinol in enterocytes. 
Approximately one-sixth of dietary B-carotene is absorbed and 
converted to retinol in humans (17, 18). Two major hypotheses 
proposed for formation of vitamin A from carotene are: 1) 
central cleavage of B-carotene to yield two molecules of 
vitamin A (58, 120), and 2) initial cleavage of one end of the 
beta-carotene molecule followed by sequential oxidation to 
form one molecule of vitamin A (54, 150). 
Reports published in 1965 by two different laboratories 
confirmed the hypothesis of central cleavage of beta-carotene 
to form two molecules of vitamin A (58, 120). The enzyme, 
designated B-carotene 15-15' oxygenase, was a soluble protein 
found in intestinal mucosa and liver of rats. It was proposed 
that cleavage of beta-carotene resulted in formation of two 
molecules of retinal. Researchers had shown that one molecule 
of beta-carotene disappeared with the appearance of two 
molecules of retinal (58), and neither beta-apo carotenals 
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(products that would result from sequential oxidation) nor 
other products were found in the reaction mixture (120). The 
existence of beta-carotene 15-15' oxygenase as well as the in 
vitro requirement for bile salts or synthetic detergents were 
later confirmed (59). Another study reported that the 15-15' 
double bond of naturally occurring apo-carotenals also is 
cleaved by the carotene cleavage enzyme, resulting in the 
production of retinal, rather than by the stepwise cleavage 
pathway (90). 
Questions regarding formation of vitamin A from fi-
carotene persisted. Other researchers reported formation of 
several apocarotenals and apocarotenic acids in the intestine 
of rats and chickens (150). They suggested that B-carotene is 
cleaved at several double bonds, although the primary cleavage 
is at the central double bond. Hansen and Maret in 1988 (63) 
reported that retinal is not formed by the central cleavage of 
beta-carotene. They used the method of preparation of rat 
Intestinal mucosa published by Goodman and Olson (60), 
followed by solvent extraction of retinoids and carotenoids 
for HPLC analysis. They did not detect any central cleavage 
or random cleavage products in the mucosa. 
Lakshman et al. (89) repeated the original experiments of 
Goodman and Huang (58) and Olson and Hayaishi (120), and 
verified that retinal is the major product of the fi-carotene 
cleavage enzyme. Several reasons were proposed for 
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differences in the findings. Hansen and Maret (63) did not 
report the use of reagents to protect sulfhydryl units of the 
enzyme as had been done in the original studies (58, 120}. 
Hanson and Maret did not report the recovery of retinal added 
to the system so it could not be determined if the recovery of 
product might have been poor (63). Thirdly, Hansen and Maret 
evidently did not remove other possible interfering enzyme 
activities such as retinal oxidase or retinal reductase so 
that the true activity of the fi-carotene cleavage enzyme could 
be determined (63). Current research continues to examine 
mechanisms of the cleavage reaction to further elucidate the 
conversion of beta-carotene to vitamin A. 
Both retinal formed from cleavage of beta-carotene in the 
small intestine and retinol absorbed from the diet bind to 
cellular retinol-binding protein type II (CRBP-II) in the 
small intestine of adult animals (39, 95, 121, 124, 139). 
Another cellular retinol-binding protein, designated as CRBP-
I, had been suggested as a carrier protein for retinol in 
enterocytes. However, CRBP-I recently was shown to be present 
in the intestine only in connective tissue in the lamina 
propria and in gut-associated lymphoid tissue. In contrast, 
CRBP-II is present in epithelial, or absorptive, cells of the 
small intestine (39). Additionally, CRBP-II, but not CRBP-I, 
binds all-trans-retinaldehyde (95). Localization of CRBP-II 
in absorptive cells and its capacity to bind retinal suggest 
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that CRBP-II is involved in absorption of dietary retinol and 
reduction of retinal in the intestine (39, 95, 121). 
Retinal produced in enterocytes mainly is reduced to 
retinol by retinal reductase in both cytosol and microsomes 
(17, 78, 119, 145). Activity Of the microsomal enzymes is 
eight times greater than activity of the cytosolic enzymes, 
and it requires either NADH or NADPH as a cofactor (78). 
Dietary retinol binds to CRBP-II and is transported from the 
plasma membrane to microsomes (endoplasmic reticulum) (122). 
Dietary retinol and retinol formed by reduction of retinal 
both remain bound to CRBP-II; thus, there is little retinol 
available for oxidation back to retinaldehyde. These 
reactions favor export of retinol from enterocytes (78). 
Several studies provide evidence that the CRBP-II-retinol 
complex is a substrate for lecithin:retinol acyltransferase 
(LRAT), an enzyme in the microsomes of intestinal cells that 
esterifies retinol to retinyl esters (68, 96, 122, 141). Ong 
et al. reported that the acyl portion of retinyl esters are 
from an endogenous acyl donor (122). When the researchers 
presented CRBP-II-retinol complexes to LRAT, the resulting 
retinyl esters contained palmitate, stearate, linoleate, and 
oleate in the same proportions as are found in chylomicrons 
and in whole lymph (122). Specifically, palmitate is the 
predominant acyl moiety in retinyl esters, and stearate is 
second. In contrast, addition of free retinol to the system 
r 
17 
resulted in a decrease in the proportion of retinyl esters 
containing palmitate (122). Further studies showed that when 
exogenous phosphatidylcholine (PC) was supplied to an in vitro 
system, the sn-l-acyl moiety of PC was transferred to retinol 
complexed to CRBP-II, resulting in formation of retinyl esters 
(96). These results indicate that LRAT is the enzyme in 
enterocytes responsible for most of the esterification of 
retinol under normal conditions and that PC is the endogenous 
acyl donor (96, 122). 
Research suggests that when large amounts of retinol are 
present in the diet, available CRBP-II becomes saturated with 
retinol, and free retinol in the membranes can be esterified 
by acyl CoA:retinol acyltransferase (ARAT) (18). Retinyl 
esters formed by ARAT activity may be stored temporarily in 
lipid droplets in enterocytes until CRBP-II becomes available. 
The retinyl esters then may be hydrolyzed and reesterified by 
LRAT for packaging into chylomicrons. This temporary storage 
in intestinal cells may account for the prolonged release of 
retinyl esters into lymph from a large dietary dose of retinol 
(17). Support for this hypothesis is provided by a report 
that, although solvent-dispersed retinol is the preferred 
substrate for ARAT, retinol bound to CRBP can be esterified 
only by LRAT (143). 
It also has been reported that the gene for CRBP-II 
contains a RARE that is activated by the nuclear retinoid X 
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receptor (RXR) (101). This report led to speculation that 
higher amounts of dietary retinol may lead to greater 
concentrations of RA in enterocytes. In turn, this RA would 
lead to activation of the CRBP-II gene, resulting in increased 
expression of CRBP-II (18). Expression of the CRBP-II gene 
also may be under control of hormones other than vitamin A as 
indicated by the finding that concentrations of CRBP-II in the 
intestine are increased during pregnancy and lactation in rats 
(139). Therefore, CRBP-II may have a role in facilitated 
diffusion of retinol into enterocytes (18) as well as having 
roles in metabolism, transport, and esterification within the 
enterocyte (119). 
Storage of Vitamin A 
After esterification of retinol, retinyl esters are 
incorporated into chylomicrons which are transported to the 
Golgi apparatus for processing. The chylomicrons are secreted 
by exocytosis through the basolateral surface of enterocytes 
into the mesenteric duct lymph (17). Chylomicrons are 
transported in thoracic duct lymph until they enter the 
general circulation (17). Chylomicron remnants are formed by 
the action of lipoprotein lipase (LPL), which is located on 
vascular endothelial cells, especially in muscle and adipose 
tissue (17, 119). Lipoprotein lipase hydrolyses 
triacylglycerols found in chylomicrons. Other components of 
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chylomicrons, including beta-carotene, are transferred to 
other lipoproteins or to cell membranes. The majority of 
retinyl esters remain with the chylomicron remnant and are 
transported to the liver; however, there is some uptake of 
retinol from chylomicrons by extrahepatic tissues (17). 
Tissues that have been shown to sequester significant amounts 
of retinyl esters from chylomicrons include adipose tissue, 
skeletal muscle, and kidneys, as well as spleen in rats and 
guinea pigs. Chylomicron remnants also are cleared by bone 
marrow macrophages in rabbits and marmosets (17). 
Chylomicron remnants are taken into liver parenchymal 
cells via a receptor-mediated process that involves the LDL 
receptor and/or the LDL receptor-related protein (17, 18, 
145). After uptake, retinyl esters are hydrolyzed rapidly by 
retinyl palmitate hydrolase (16, 17, 18, 66). The retinol is 
carried by CRBP through the cytoplasm to the endoplasmic 
reticulum where it binds to retinol-binding protein (RBP) (17, 
18, 64). The RBP-retinol complex then is transferred to Golgi 
for secretion (17, 18). Depending on the vitamin A status of 
an animal, secreted RBP-retinol either enters the circulation 
or is stored by hepatic stellate cells (9, 10, 13, 17, 19, 66, 
91). Approximately 80% of retinol in livers of animals with 
normal vitamin A status is stored in stellate cells, and 
greater than 95% of this is stored as retinyl esters (10, 13, 
19, 91). In rats with low vitamin A status, most of the 
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vitamin A in liver was located in parenchymal cells (9). The 
mechanism for transfer of retinol from hepatic parenchymal 
cells to hepatic stellate cells is not known. It has been 
suggested, however, that the transfer may be mediated by RBP 
because antibodies to RBP prevented accumulation of vitamin A 
by stellate cells from rat livers prefused in situ (16). 
Free retinol in liver is esterified by LRAT or ARAT, but 
the carrier in liver is predominantly CRBP-I rather than CRBP-
II. Only CRBP-I is found in adult liver cells, but both CRBP-
I and CRBP-II are found in liver cells from 3-d-old rats 
(123). This difference may indicate a greater need for 
storage capabilities in young animals (123). The 
concentration of CRBP-I is enriched greatly on a per mg of 
protein basis in stellate cells, which is consistent with 
their role as the storage site for vitamin A (13, 19, 66). 
Free retinol is esterified by both ARAT and LRAT, but retinol 
bound to CRBP is esterified only by an acyl CoA-independent 
enzyme that is probably LRAT (97, 123, 143) . As in 
enterocytes, retinyl esters produced by the enzyme utilizing 
an endogenous acyl donor were in the same proportions as found 
in liver (97, 123). 
As described already for enterocytes, LRAT functions 
under normal vitamin A loads, and ARAT functions when dietary 
amounts of vitamin A are high. Activity of ARAT increased 1.5 
fold in liver of normal rats fed 2 mg of retinyl acetate daily 
r 
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for 18 to 19 d (7) and is high in both parenchymal and 
stellate cells (19). In rats with low vitamin A status, 
hepatic LRAT activity declined, whereas hepatic ARAT activity 
remained constant (141). Hepatic LRAT activity was restored 
rapidly when rats were repleted with vitamin A (141). Because 
LRAT activity varies with vitamin A status, it is probably the 
key enzyme involved in hepatic esterification of retinol 
(141) . 
Release of Vitamin A from Liver 
Mobilization of retinol from liver requires hydrolysis of 
retinyl esters. On a per mg of protein basis, retinyl-
palmitate hydrolase activity was similar in parenchymal and 
stellate cells (13, 19, 66). Although it is not known whether 
CRBP-I or RBP is the acceptor for retinol after hydrolysis of 
retinyl esters, there are indications that CRBP-I plays a 
significant role in mobilization of retinol from liver. 
Concentrations of CRBP-I are high in both parenchymal and 
stellate liver cells of normal rats (13, 66). Additionally, 
pregnant and lactating rats, which have a greater requirement 
for mobilization of retinol, also exhibit increased amounts of 
CRBP mRNA (94). CRBP-I may act as a buffer in the cytoplasm 
by either limiting unesterified retinol concentrations or 
maintaining unesterified retinol concentrations (145). 
Retinol is mobilized from the liver bound to RBP in a 
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one-to-one molar complex. It is not known whether retinol 
must be transferred back to parenchymal cells before secretion 
or whether RBP-retinol is secreted directly from stellate 
cells. Presence of RBP mRNA in stellate cells and secretion 
of RBP-retinol from stellate cells in vitro suggests that 
retinol is mobilized directly from stellate cells in vivo 
(17). It also has been suggested that apoRBP can bind to 
stellate cells and complex with retinol from those cells. The 
holoRBP then can be released into the circulation (18). 
In most species, RBP complexes in plasma with 
transthyretin (TTR), a tetramer that binds thyroxine (119). 
This complex, because of its large size, may be important in 
decreasing urinary loss of RBP as the complex passes through 
the kidneys. 
Transport of Vitamin A and B-carotene 
Vitamin A reaches extrahepatic tissues through a variety 
of processes. Retinyl esters can be carried to cells on 
chylomicrons; retinol can be transported to cells complexed 
with RBP; and RA can arrive at the cell surface bound to serum 
albumin and presumably enters the cell by diffusion (145). In 
addition to retinoids, beta-carotene can enter cells from 
chylomicrons or LDL. Recently, evidence has been reported for 
direct generation of RA from beta-carotene in several tissues 
of rats and rabbits (49, 110). 
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Cellular Uptake of Retinol 
It is estimated that only about half of the retinol 
released from liver is taken up by peripheral tissues (119). 
The rest is returned to the liver. Additionally, retinol 
taken up by peripheral tissues may be secreted as RBP-retinol 
and returned to the liver (142). The source of RBP for 
recycling from extrahepatic tissues is not known, but several 
tissues express RBP mRNA (18). A retinol molecule may 
circulate between the liver and plasma seven to thirteen times 
before being degraded irreversibly (18). The whole-body 
utilization rate of vitamin A has been estimated to be only 
about 10% of the plasma retinol turnover rate (18). 
Two models have been proposed for uptake of retinol 
(145). In the aqueous-diffusion model, entry of retinol into 
cells is limited by the rate of extracellular dissociation of 
retinol from RBP. The major functions of RBP in the aqueous 
diffusion model are to solubilize retinol, prevent oxidative 
damage to the retinol molecule, and limit entry of retinol 
into cells (113, 142). Research suggests that retinol 
concentrations are in equilibrium between RBP in serum and 
CRBP in cells (113). Also, retinol bound to RBP or to RBP-TTR 
enters cells more slowly than does free retinol (38, 142). 
The second model proposes that RBP-retinol is taken up by 
specific cell surface receptors for holoRBP (145, 149, 160). 
In this model, the protein portion of holoRBP binds to a 
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specific receptor; the complex is internalized by receptor-
mediated endocytosis; retinol is released into the cytoplasm; 
and apoRBP then is degraded or secreted from the cells. 
Research by Senoo et al. Indicates that parenchymal and 
stellate cells in liver bind holoRBP with receptors and 
internalize the complex (149). 
Different tissues may have different mechanisms of 
acquiring retinol based on the function of the specific 
tissue. Retinal pigment-epithelial cells have a specialized 
requirement for retinol, and liver cells function in storage 
of vitamin A. Therefore, these cells may express receptors 
for RBP to improve uptake of retinol, whereas other cells may 
be able to acquire enough retinol by the acqueous diffusion 
method. 
Intracellular metabolism 
In extrahepatic tissues, retinol binds to CRBP, which 
serves to direct the retinol to an alcohol dehydrogenase for 
oxidation to retinaldehyde (88, 145). The alcohol 
dehydrogenase that recognizes ethanol as a substrate was 
assumed to be the dehydrogenase that converts retinol to 
retinaldehyde. However, there is evidence of a cytosollc 
dehydrogenase that is specific for retinol based on the 
ability of the ethanol dehydrogenase negative deermouse to 
synthesize RA (135). Retinaldehyde then is oxidized 
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irreversibly to RA, which is the biologically active 
metabolite in most tissues. Retinoic acid does not function 
in vision or reproduction. 
Plasma RA (approximately 3 to 8 ng/ml in humans) can 
enter cells through diffusion, but most of the RA is formed 
inside cells from retinol and, especially in carotenoid 
accumulators, ô-carotene. This allows intracellular 
concentrations of RA to exceed plasma concentrations (145). 
Because retinaldehyde does not accumulate in cells where 
retinol is used in vitro as the RA substrate, retinaldehyde 
formation is probably the rate-limiting step in RA formation 
from retinol (145). Evidence indicates that most of the RA 
from 6-carotene is formed directly from B-carotene rather than 
first requiring conversion to retinol (110). 
Cellular RA-binding proteins (CRABP) have been reported 
in several tissues. In rat liver, CRABP is found in both 
parenchymal and stellate cells but is more concentrated in 
stellate cells on a per mg protein basis (13, 19, 66). In 
mouse embryos, CRABP is not found in significant 
concentrations in regions such as dermis and epidermis that 
express nuclear RAR at high levels (43). This distribution 
suggests that one role of CRABP may be to sequester RA and 
protect cells from toxic effects (43). Another role of CRABP 
may be to increase the rate of metabolism of RA as indicated 
by an increase in the number of RA metabolites when an excess 
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of CRABP was added to a system containing microsomes from rat 
testes (47). Several isomers and analogs of RA, including 1 3 -
cis-RA, can bind to CRABP (47). The lower affinity of CRABP 
for 13-cis-RA than for all-trans-RA makes 13-cis-RA less 
active biologically and less toxic than all-trans-RA (47). 
Another RA binding protein, CRABP-II, is present in human 
skin (6) and mouse embryos (166). Although the mRNA for 
CRABP-II in mouse embryos is increased by RA treatment of the 
dams (166), a role for CRABP-II in RA metabolism has not yet 
been determined. 
Effects of RA are mediated through nuclear RAR and RXR, 
which are members of the steroid/thyroid hormone receptor 
superfamily. In 1987, identification of the first nuclear 
RAR, RAR-a was reported for human breast cancer cells (134) 
and human testis and kidney (55). The RAR has a strong 
similarity to the thyroid hormone receptor and can bind a 
thyroid hormone response element (TRE) to activate gene 
expression (173). A second and third RAR, termed RAR-8 and 
RAR-r, subsequently were identified (11, 22, 87). Retinoic 
acid receptor-S was shown to be expressed in several 
epithelial tissues, including trachea, whereas RAR-r is 
expressed in skin and chondrogenic regions (133, 144). 
Expression of RAR-a is ubiquitous and constitutive whereas 
expression of RAR-8 is inducible (133, 144). 
A second pathway of vitamin A action in cells is mediated 
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through RXR (100). All-trans-RA has high affinity for RAR but 
low affinity for RXR. The search for a ligand for RXR 
reve a l e d  t h a t  9 - c i s - R A  b o u n d  R X R  w i t h  h i g h  a f f i n i t y  ( 6 9 ,  9 3 ) .  
Researchers also reported that RXR, unlike RAR, is present in 
visceral tissues, i.e., liver, muscle, lung, kidney, and heart 
(100). Further examination revealed that there are three 
separate genes that encode RXR isoforms designated RXR-a, RXR-
8, and RXR-r (99). 
Nuclear RAR bind with high affinity to RARE only when 
they form heterodimers with RXR. In contrast, RXR homodimers, 
in the presence of 9-cis-RA, bind to RXRE with high affinity 
(146). This affinity suggests that, as cell concentrations of 
all-trans and 9-cis RA are altered, the equilibrium between 
RAR-RXR heterodimers and RXR-RXR homodimers may shift, 
resulting in altered gene expression (146). 
Nuclear RAR and RXR also form heterodimers with other 
members of the steroid/thyroid hormone receptor superfamily. 
Formation of RAR or RXR heterodimers with thyroid hormone 
nuclear receptors (TR) enhances binding affinity to TRE and 
thyroid hormone dependent transcriptional activation (146). 
Likewise, formation of RXR and vitamin D, nuclear receptor 
(VDR) heterodimers enhances binding affinity to vitamin D, 
response elements (VDRE) and vitamin D, dependent 
transcriptional activation (146). 
Identification of RAR and RXR specific for different 
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isoforms of RA Indicates that isomerization may be as 
important in other aspects of vitamin A action as it is in 
vision. Different sets of genomic response elements may be 
regulated by different RAR and RXR (146). Existence of 
nuclear retinoid receptors confirms what has been suspected 
for many years, that vitamin A acts by affecting gene 
expression. 
Homeostasis 
Plasma retinol concentrations are maintained within a 
relatively narrow range even with wide fluctuations in dietary 
vitamin A. Means of achieving this homeostatic regulation are 
not known, but several reports provide evidence that RA is 
involved. Underwood and coworkers (174) reported that rats 
fed a vitamin A-deficient diet maintain normal plasma 
concentrations of retinol until liver retinol concentrations 
decrease below 10 ng/g. If the rats are supplemented with RA, 
plasma concentrations of retinol drop below concentrations in 
rats fed the vitamin A-deficient diet without RA 
supplementation (82, 174). The authors speculated that 
administration of RA adjusts the homeostatic setpoint downward 
so that the liver releases only the amount of retinol required 
to meet tissue needs not supplied by RA. Alternatively, the 
increased RA could be seen as a false indication of adequate 
vitamin A status by the liver because RA normally is not seen 
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in large quantities. 
Other researchers have provided evidence indicating that 
increases in RA concentrations influence LRAT activity, 
resulting in increased storage of vitamin A (106, 141). In 
addition, ARAT activity is increased during episodes of high 
vitamin A intake (7, 119). When vitamin A status was low in 
rats, hepatic LRAT activity was decreased (141). 
Administration of RA to vitamin A-deficient rats resulted in 
increased hepatic LRAT activity, and this increase required 
new RNA synthesis, which was indicated by blockage of 
increased LRAT activity by administration of Actinomycin D 
(106). The increase in activity was greatest in 
nonparenchymal cells. The authors suggested that RA is the 
form of vitamin A that regulates LRAT activity and, therefore, 
the capacity for vitamin A storage. 
One possible mechanism of homeostatic regulation is that 
an equilibrium is maintained between plasma retinol and 
cytoplasmic retinol in the liver (18, 113). Retinol interacts 
with CRBP-I three- to fivefold faster than it interacts with 
RBP, which would favor movement of retinol from plasma to 
liver cells (113). Also, the concentration of CRBP-retinol is 
nearly equal to the concentration of plasma RBP-retinol (64, 
113). Therefore, regulation of the CRBP-I concentration in 
stellate cells may be Involved in regulation of plasma retinol 
concentrations. Additionally, Increases in CRBP-I during 
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pregnancy and lactation, when drains on plasma retinol should 
be high, indicate a role of CRBP-I in maintaining plasma 
retinol homeostasis (94) . Again, there is evidence that RA is 
involved in regulation of CRBP-I concentrations because of the 
discovery of RARE in the CRBP-I gene (165). 
The CRBB-II gene is also a target of RA (101). 
Interestingly, CRBP-II gene expression is activated by RXR but 
is inhibited by coexpression of RAR and RXR. These 
observations suggest that RA isomers play a central role in 
plasma retinol homeostasis. 
Role of Vitamin A in Immunity 
Overview of the Immune System 
The immune system is divided into two general branches. 
These are the innate branch and the adaptive branch. The 
innate branch of the immune system includes phagocytic cells, 
such as neutrophils, and soluble substances, such as 
complement, that are constitutive in animals. Their role in 
prevention of infection is nonspecific. In contrast, the 
adaptive branch of the immune system includes cells and 
soluble substances that recognize specific antigens and are 
responsible for the generation of "memory". Memory is the 
ability of the immune system to respond to a second exposure 
to an antigenic substance in a much more rapid and specific 
manner, and with a greater magnitude than it did upon initial 
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exposure to the antigen (57). Antigen presenting cells (APC), 
lymphocytes, cytokines, and antibodies are important 
components of the adaptive branch of the immune system. This 
review of literature will focus on mechanisms of the adaptive 
branch of the immune system. 
Immune Response 
A type of cell that bridges the innate and adaptive 
branches of the immune system is the antigen presenting cell 
(APC, macrophage and B-cell). The macrophage functions as a 
phagocytic cell (innate branch) and as an APC (adaptive 
branch). When a foreign object bearing an antigen is 
encountered by a macrophage, it is engulfed and digested. 
Processed antigen can be presented on the surface of the 
macrophage in association with a major histocompatibility 
complex (MHC) class II molecule (104). This antigen is 
"recognized" by specific molecules on the surface of T-cells, 
called T-cell receptor (TCR) complexes, and an immune response 
is initiated (35). The CD4* T-cell binds to the antigen in 
association with the MHC class II molecule through the TCR 
(20). T-cells bearing CD4 antigens normally are considered to 
be T-helper cells and function to drive proliferation of cells 
involved in the immune response (57). Upon binding of the T-
helper cell, the macrophage releases a soluble protein, 
interleukin 1 (lL-1), which is involved in activation of the 
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T-cell. The helper cell clone proliferates and releases IL 
that act on other cells. 
In mice and humans, the types of IL released by the T-
cell determine whether it is a T-helper 1 (THl) or T-helper 2 
(TH2) cell (168). In general, THl cells drive a 
cytotoxic/inflammatory response and TH2 cells drive an 
antibody response. It is likely that T-helper cells can be 
divided into these functional types of cells in species other 
than mice and humans, although it has not yet been 
demonstrated. Interactions of cells culminating in an immune 
response are numerous and complex and, therefore, have not 
been elucidated completely. 
Recent studies indicate that, in the generation of an 
antibody response, TH2 cells secrete IL-4, IL-5, and IL-6 
(168). These IL are considered to induce growth and 
differentiation of B-cells resulting in production of IgM, 
igA, IgGl, and IgE. After activation, B-cells also can act as 
APC which results in amplification of the immune response. 
Under circumstances where concentrations of interferon-r 
(IFN-T) concentrations are low, THl clones can induce B-cells 
to produce IgG2a (168). This antibody is involved in fixing 
complement, thereby enhancing cytotoxicity. Normally, THl 
clones secrete IL-2, IFN-r, and TNF-fi (lymphotoxin). This 
cytokine secretion pattern is effective in promotion of 
delayed type hypersensitivity (DTH) reactions and generation 
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of cytotoxic T-cells (CD8* T-cells) (57, 168). 
Normally, immune responses are either DTH or antibody 
producing in nature, which suggests that THl and TH2 cells are 
"reciprocally regulated" in vivo (168). In vitro 
proliferation of TH2 cells is inhibited by IFN-T, a cytokine 
produced by THl cells. Alternatively, IL-4 and IL-10 produced 
by TH2 cells inhibit proliferation and cytokine secretion by 
THl cells (168). 
The eventual result of either type of immune response is 
the generation of memory cells (168). Memory B-cells and 
memory T-helper (THm) cells are generated in an antibody 
producing response, whereas only THm are produced in a DTH 
type of response. These THm cells are long-lived and secrete 
mainly IL-2 upon secondary stimulation (168). 
In contrast to CD4* T-cells, CD8* T-cells generally 
respond to antigen in association with MHC class I molecules, 
resulting in a cytotoxic response (115). In mice, however, 
some clones of CD8* T-cells have a helper effect, whereas some 
clones of CD4* T-cells have a cytotoxic effect (158). 
Traditionally, CD8* cell growth is considered dependent on CD4* 
T-cell help based on experiments that have demonstrated a 
requirement for the presence of MHC class II* macrophages for 
proliferation of CD8* cells (178). As is the case for CD4* 
cells and B-cells, CD8* memory cells are generated as part of 
the immune response involving cytotoxicity (115). 
» 
34 
Vitamin A and Immune Function 
Research Involving Mice. Rats, and Chickens Early 
research indicated that vitamin A had an important role in 
Immune function apart from maintaining healthy epithelium as a 
physical barrier to infection. Mice supplemented with vitamin 
A palmitate and infected with three different types of 
microorganisms were able to resist infection much better than 
did unsupplemented controls (37). The mechanism of resistance 
was unknown, but researchers suggested it may have been the 
result of enhanced phagocytic activity (37). Recently, 
researchers have tried to elucidate that role. Studies have 
shown that hematopoietic cells of different lineages express 
mRNA for RAR-a at several stages of differentiation (86). 
This expression indicates that vitamin A probably functions 
through RA to mediate functions of many types of Immune cells. 
Vitamin A deficiency has been reported to Impair 
nonspecific Immune function. Rats with experimentally Induced 
vitamin A deficiency were less able to clear injections of E. 
coll than were vitamin A-sufficient rats (125). Additionally, 
in vitro phagocytic activity of neutrophils from vitamin A-
deflcient rats was impaired (125). Function of macrophages 
also was affected by vitamin A. Vitamin A or RA 
supplementation significantly enhanced resistance to 
Mycobacterium tuberculosis and Salmonella tvphimurium (40, 
65). 
I 
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Cohen and Cohen reported in 1973 that vitamin A used as 
an adjuvant in mice increased the number of plague cells from 
the spleen in response to sheep red blood cells (36). Hayes 
and coworkers conducted a series of studies to determine 
effects of vitamin A deficiency on immune function of mice 
(29, 30, 34, 163, 164). Both cellular (DTH) and humoral (IgM 
production) immunity were decreased in vitamin A-deficient 
mice (164). These effects were observed even though there 
were no alterations in T-cell numbers. There were, however, 
increased B-cell numbers in lymph node and spleen (164). 
Subsequently, it was reported that IgM and IgG responses were 
impaired in vitamin A-deficient mice, but IgG response was 
affected to a greater extent (163). Antibody production was 
lower because there were fewer antibody-secreting cells from 
spleens of deficient mice. This decrease was attributed to an 
adverse effect of vitamin A deficiency on T-helper cell 
func t i o n .  T h e y  h y p o t h e s i z e d  t h a t  i n t e r l e u k i n  s e c r e t i o n  b y  T -
helper cells had been altered. 
A study based on this hypothesis revealed that T-helper 
cell frequency was lower in vitamin A-deficient mice (30). 
Additionally, results indicated that Th2 cells were probably 
the T-helper type impaired (30). Vitamin A-deficient mice 
were supplemented with retinol, retinyl acetate, 
retinaldehyde, or RA to determine the most active metabolite 
for restoring immune function (34). Retinoic acid restored 
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IgG responses and T-helper cell frequencies at least 10-fold 
better than did the other retinoids tested (34). These 
results suggest that RA is the active metabolite of vitamin A 
responsible for maintaining IgG, responses in mice. 
Investigation of the immune responses of vitamin A-
deficient mice to Trichinella spiralis infection revealed that 
the outcome of infection was the same in both vitamin A-
deficient and control mice (29). Cytokine secretion was 
altered by vitamin A-deficiency, however, toward a pattern 
characteristic of induction of cellular responses (increased 
IFN-r secretion) rather than antibody responses (29). 
Ross and coworkers have studied effects of vitamin A 
deficiency on immune function of rats (79, 85, 128, 129, 130, 
131). They used the antibody response to the capsular 
polysaccharide of Streptoccocus pneumoniae, type III (SSS-III) 
as an indication of the ability of rats to produce antibody. 
In mildly vitamin A-deficient rats, IgM production in response 
to immunization with SSS-III was decreased relative to 
controls (79, 128, 129). The decrease in antibody production 
occurred prior to clinical manifestations of vitamin A 
deficiency, and responses could be restored with 
supplementation of either retinol or 6-carotene. 
A subsequent trial investigated the antibody responses of 
vitamin A-deficient rats to type 1 and type 2 antigens as well 
as to T-cell dependent antigens (130). Type 1 antigens elicit 
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an antibody response completely independent of T-cells, 
whereas type 2 antigen responses are regulated by T-cells. 
Activation of B-cells in response to T-dependent antigens 
requires T-cell help. The magnitude of antibody responses to 
both type 2 and T-dependent antigens was dependent on vitamin 
A status. In contrast, antibody responses to type 1 antigens 
did not differ between vitamin A-deficient and -replete rats. 
These results suggested a possible T-cell defect in vitamin A-
deficient rats and supported the results of Hayes and 
coworkers. Later research, however, failed to reveal a 
difference in proportions of T-helper or T-suppressor cells 
(131). 
Ross and coworkers also determined that immunological 
memory was established in vitamin A-deficient rats challenged 
with tetanus toxoid, a T-dependent antigen (85). Although 
magnitudes of the responses were lower in vitamin A-deficient 
rats ,  r e s u l t s  i n d i c a t e d  t h a t  m e m o r y  w a s  es t a b l i s h e d  b y  bo t h  T -
cells and B-cells. 
Many studies support the role of vitamin A in antibody 
production. A common finding is decreased immunoglobulin 
production in vitamin A deficient mice, rats, and chickens (4, 
52, 53, 127, 159). Several studies alsohave found decreases 
in either circulating B-cells, plaque forming cells, or 
responses of B-cells to bacterial lipopolysaccharide (LPS) 
(32, 111, 175). 
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As further support for the role of vitamin A in immune 
function, studies of vitamin A-deficient mice, rats, and 
chickens indicate cell-mediated immunity (CMI) is impaired. 
Both DTH and lymphocyte responses to mitogens are altered in 
vitamin A-deficient animals (4, 27, 32, 52, 53, 102, 103, ill, 
112). In contrast to these findings, there are some studies 
where no effect of vitamin A-deficiency on CMI was found (127, 
175). In the latter studies, female rats were used. 
In a study by Pasatiempo et al. (129), differences were 
reported between responses of male and female rats to vitamin 
A-deficiency. In male rats that were vitamin A-deficient, 
spleen weights, splenic lymphocyte numbers, and antibody 
response to SSS-III were lower compared with those of control 
male rats. In female rats, there were no differences in 
spleen weights and splenic lymphocyte numbers between vitamin 
A-deficient and control animals. Antibody response to SSS-III 
was numerically lower in vitamin A-deficient female rats 
compared with those of control female rats, but the difference 
was not statistically significant. These studies indicate 
there may be differences in the ways male and female rats 
respond to vitamin A-deficiency, which may be a result of 
differences in sex hormones between male and female rats. 
Several researchers determined effects of excess 
administration of vitamin A to animals. These effects include 
enhanced host-versus-graft responses (98, 167), greater cell-
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mediated cytoxicity (42), and inhibited tumor cell growth 
resulting from T-cell stimulation (132). In chickens, excess 
vitamin A (35 mg/kg diet) had little effect on antibody 
production and proliferative responses in vitro (52). In 
contrast, very large levels of vitamin A (1,000 mg/kg diet) 
resulted in impaired antibody production and proliferative 
responses (52). 
Resistance to experimental infections with various 
pathogens was examined in vitamin A-supplemented and vitamin 
A-deficient animals. Mice supplemented with toxic doses of 
vitamin A were better able to resist bacterial infections than 
were mice fed normal diets (70, 71). Results indicate there 
was an increase in function of the monocyte/macrophage system 
and the T-cell system. Chickens receiving no dietary vitamin 
A exhibited increased susceptibility to E. coli compared with 
chickens fed a vitamin A-sufficient (.85 mg/kg) diet (51). In 
addition, chickens that received excessive vitamin A (1000 
mg/kg diet) also were more susceptible to bacterial infection 
(51). Such excessive levels may have been toxic to the birds, 
resulting in increased susceptibility to infection. 
In vitamin A-deficient animals, the ability to clear an 
influenza virus was not different from that in normal animals 
(167). In contrast, Watson et al., (177) found that vitamin A-
supplemented mice had better resistance to murine leukemia 
virus than normally fed mice. Vitamin A supplementation 
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increased numbers of macrophages and B cells. It also 
increased the numbers of cells bearing activation antigens 
(MHC class II molecule and IL-2R) in uninfected mice. 
Overall, the death rate of infected mice supplemented with 
vitamin A was lower than the death rate of infected mice fed 
normal diets (177). 
Chickens that were marginally deficient in vitamin A 
exhibited greater morbidity when infected with Newcastle 
disease virus (NOV) than were nondeficient chickens (157). 
Additionally, plasma retinol concentrations decreased in 
deficient chickens that were infected with NOV compared to 
deficient chickens that were not infected (157). This result 
is a compounding factor that makes it difficult to discern the 
cause and effect relationship. A subsequent study 
demonstrated that cytotoxic T-cell activity was impaired in 
vitamin A-deficient chickens (156). 
Responses of mice and rats to infections with parasites 
are mediated by vitamin A status. Vitamin A-deficient rats 
were more susceptible to infections with parasites than were 
normal rats (41, 127). Vitamin A-deficient rats infected with 
Schistosoma mansoni exhibited lower IgE concentrations than 
did normal rats infected with the parasite (127). The vitamin 
A-deficient rats also had a greater adult worm burden (127). 
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Research Involving Humans Epidemiological studies 
indicate vitamin A is very important for prevention of 
infectious diseases in humans. Bacteria were more able to 
bind to respiratory epithelial cells from vitamin A-deficient 
children than to comparable cells from vitamin A-sufficient 
children (31). This is an excellent example of the importance 
of vitamin A for maintaining healthy epithelium as a physical 
defense against infection. 
Children in India who were given a weekly vitamin A 
supplement had a lower mortality rate than did children given 
a placebo (140). In South Africa, children hospitalized with 
measles were given retinyl palmitate (400,000 lU) or a placebo 
(73). Children who received retinyl palmitate had shorter 
hospital stays, less croup, shorter recovery times for 
pneumonia and diarrhea, and a lower mortality rate than did 
children who received the placebo. 
The mode of action of vitamin A in immune function has 
not been determined. Reports of the effects of vitamin A on 
immune responses of human lymphocytes have differed. Retinol 
has been reported to inhibit proliferation of human 
lymphocytes in response to the mitogen, phytohemagglutinin 
(PHA) and phorbol myristate acetate (PMA) (161). In contrast, 
RA has been reported to enhance proliferation in response to 
PHA and antihuman-thymocyte globulin, whereas response to the 
mitogens, concanavalin A (Con A) and pokeweed mitogen (PWM), 
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was not altered (2). 
Isakov (1988) attempted to determine the mode of action 
of vitamin A in immune cells (74). He studied effects of 
retinal and RA on activation of protein kinase C (PKC) derived 
from human leukemic T-cells. (Protein kinase C is an enzyme 
involved in transmembrane signalling, and it regulates events 
leading to growth and differentiation in cells.) Isakov 
reported that retinal inhibited PKC whereas, RA activated PKC 
(74). These results suggest that different derivatives of 
vitamin A have different effects on T-cells. Also, the 
effects of vitamin A on T-cell function may be mediated 
through PKC (74). 
Alternatively, topical treatment of skin with RA 
increased numbers of CD4+ T-cells but decreased PKC activity 
(48). Tests were conducted to compare reactions to RA with 
reactions to sodium lauryl sulfate (an irritant). Reactions 
to the two compounds were indistinguisable, which suggests 
that reactions observed with topical administration of RA may 
not be unique for RA (48). 
Antibody production of subjects receiving vitamin A also 
has been affected. Administration of 13-cis RA to acne 
patients resulted in greater in vivo production of antibodies 
when subjects were immunized with keyhole limpet hemocyanin 
but not.tetanus toxoid (152). Another study reported 
increased antibody production in response to immunization 
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against tetanus when Indonesian children were treated with 
60,000 fig of retinol equivalent (148). Supplementation with 
either RA or retinol also increases production of monoclonal 
antibody by human-human hybridomas (5). 
Sidell et al. (153) reported that RA increased formation 
of antibody-producing cells from human tonsillar lymphocytes 
in response to SRBC. Incubation of T-cells with RA prior to 
combining lymphocytes with SRBC inhibited the formation of 
antibody-producing cells. In contrast, incubation of B-cells 
with RA prior to combining lymphocytes with SRBC resulted in 
enhanced formation of antibody-producing cells (153). The 
authors suggested that RA directly affected B-cells. In 
support of these results, RA has enhanced production of 
antibody from human B-cell hybridomas (151). 
In contrast to Sidell et al. (153), Israel et al. 
reported that preincubation of T-cells with RA, prior to 
combining with B-cells in culture, enhanced Ig production by 
B-cells (75). These authors suggested that effects of RA on 
human B-cells are mediated through T-cells or T-cell products. 
Other researchers reported that retinol or a metabolite 
of retinol, but not RA, affected human B-cell function 
directly (24, 25, 26, 176). Although RA could enhance Ig 
production through effects on T-cells, retinol acted directly 
on human B-cells to enhance Ig production (176). Retinol was 
essential for growth of human B-cells in serum-free medium and 
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could not be replaced with RA (26). Additionally, human B-
cells did not synthesize RA from retinol (25). The metabolite 
of retinol thought to be responsible for the effects of 
retinol on human B-cells was 14-hvdroxv-4.14-retro-retinol 
(24) . 
As evidenced by the varied reports of effects of vitamin 
A derivatives on B-cells, it is still unclear how vitamin A 
affects the immune system. Some research supports direct 
effects of RA on B-cells whereas other research supports 
effects of RA on T-helper cells. In like manner, there is 
evidence that retinol, or a metabolite of retinol other than 
RA, is the form of vitamin A that mediates B-cell action. It 
may be that retinol and RA have different pathways for 
enhancing Ig production. 
Vitamin A derivatives may mediate Immune function through 
altered cytokine secretion patterns. Recent reports indicated 
that RA upregulated IL-2R expression on thymocyte blasts (154) 
and upregulated IL-2 mRNA in a human B-cell line (12). 
Additionally, murine spleen cells and a T-cell line that were 
stimulated with Con A and supplemented with recombinant IL-2 
(rIL-2), proliferated to an even greater extent with addition 
of RA to the cultures (76). In contrast, RA treatment of a 
human T-cell line (Jurkat) resulted in an RAR-mediated 
decrease in IL-2 gene expression (45). The differences in 
results obtained may be related to the stage of 
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differentiation of the Jurkat cell line. 
Vitamin A derivatives and precursors may alter immune 
cell populations through altering cytokine secretion patterns. 
Addition of RA and 13-cis-RA to cell cultures increased the 
percentage of cells bearing the CD4 antigen (137). Also, 13-
cis-RA increased in vitro the percentage of cells bearing 
activation markers, the MHC class II molecule and the 
transferrin receptor (137). In contrast, fi-carotene, 
canthaxanthin, and retinyl beta-glucuronide increased in vitro 
the percentage of NK cells and cells bearing the IL-2R (137). 
In vivo administration of 13-cis-RA to humans (1 mg/kg daily) 
resulted in a greater percentage of circulating cells bearing 
the marker for T-helper cells, whereas B-carotene 
administration (30 mg/d) increased the percentage of 
circulating NK cells (136). Both 13-cis-RA and B-carotene 
increased the percentage of cells bearing the IL-2R, the 
transferrin receptor, and the MHC class II molecule (136). 
Retinoids and carotenoids may act on different cell 
populations, but both increased IL-2R expression. 
There is evidence that vitamin A also mediates IFN 
production. Addition of RA to cultures of human peripheral 
blood leukocytes stimulated with mitogens resulted in 
decreased production of IFN-a and IFN-r (1). Inhibition of 
IFN was greatest when RA was added at initiation of cultures. 
CD4+ T-cells from vitamin A-deficient mice overproduced IFN-r 
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and did not produce enough IgGl (28). In vitro 
supplementation of mouse cells with RA decreased IFN-T 
production (28). In contrast, vitamin A deficiency in rats 
resulted in decreased NK cell activity and decreased IFN 
production by spleen cells in response to Con A stimulation 
(21). Vitamin A apparently plays a role in IFN production but 
its effects may differ depending on the vitamin A derivative, 
the cell type, or the species. 
other cytokines have been affected by in vitro 
supplementation with vitamin A derivatives. Expression of IL-
6R was decreased on human leukocyte cell lines supplemented 
with RA, although endogenous IL-6 production was not affected 
(155). Retinoic acid supplementation enhanced IL-1 production 
of cells stimulated with PMA (105). Similarly, addition of RA 
in vitro stimulated IL-1 production by a murine macrophage 
cell line and human MNL and IL-3 production by a murine 
myelomonocytic cell line (172). 
Vitamin A and Dairv Cattle Dairy cattle have adequate 
vitamin A status when plasma vitamin A concentrations are 
above 20 ng/<il (67). Concentrations between 10 and 20 ng/dl 
are considered marginal, and, if plasma concentrations drop 
below 10 ng/dl, animals are considered deficient (67). 
Many dairy cows are naturally vitamin A compromised at 
parturition. Plasma concentrations of vitamin A decline from 
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two weeks before parturition and remain low through one week 
after parturition (56, 77, 83, 116). Some studies have found 
concentrations low enough to indicate marginal vitamin A 
status (< 20 jug/dl) at parturition (56, 83). 
Block and Farmer (1987) reported that 62 of 100 dairy 
herds tested in Quebec had concentrations of fi-carotene, a 
vitamin A precursor, that ranged from suspect (200-299 ng/ûl) 
to deficient (<100 jitg/dl) (15). Herds with the lowest 
concentrations of fl-carotene were herds fed corn silage and 
dry hay. Corn silage contains very little vitamin A precursor 
(15) . 
Calves are born with low hepatic (7 ng/g) (23) and plasma 
(<20 jug/dl) (8, 67) concentrations of vitamin A. Colostrum is 
an early and extremely important source of fi-carotene and 
vitamin A for neonatal calves. Colostrum has been reported to 
contain from about 300 ng/dl (23) up to 430 fig/dl (77) of 
vitamin A. The high concentrations of vitamin A in colostrum 
partially account for the decrease in vitamin A in plasma of 
cows at parturition. With adequate colostrum intake, hepatic 
and plasma concentrations of vitamin A in calves are elevated 
above marginal levels within a few days. However, calves are 
immunosuppressed from 15 days prior to birth through 
parturition (28). This period corresponds to the time when 
plasma levels of vitamin A are declining in the dams (56, 77, 
83, 116). When beef cows were supplemented with intramuscular 
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injections monthly for three months, calves had higher birth 
weights and increased mean corpuscular volume, protein, and 
globulin in blood than did calves from untreated cows (3). 
These results suggest that vitamin A supplementation to cows 
prior to parturition may promote formation of erythrocytes and 
enhance antibody production. Although other variables such as 
hormone concentrations may affect the immune system, low 
vitamin A concentrations in calves seem to contribute to 
depressed immune function at parturition. 
Also at parturition, immune function in cows is 
suppressed (80, 81). There is a high rate of mammary 
infection during the periparturient period (117, 162). 
Studies have suggested a correlation between higher rates of 
mastitis in dairy cows and low vitamin A status (33, 77). 
Additionally, supplementation of diets with vitamin A and 13-
carotene above National Research Council recommendations has 
been reported to decrease the incidence and severity of 
mastitis after parturition (114, 147). In contrast, Oldham et 
al. (116) found no effect of vltmin A and B-carotene 
supplementation on incidence of mastitis. 
Studies were conducted to determine how vitamin A and R-
carotene affect immune function of dairy cows. Kensler and 
Mueller (84) demonstrated that addition of PMA to bovine 
lymphocyte cultures stimulated with PHA enhanced DNA 
synthesis, whereas concurrent addition of RA inhibited this 
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synergistic effect. Although DNA synthesis was inhibited by 
RA, RNA and protein synthesis were unaffected. Therefore, RA 
may affect the types of proteins synthesized. 
Dairy cows were supplemented with adequate vitamin A 
(53,000 lU/d), high vitamin A (213,000 lU/d), or adequate 
vitamin A plus 6-carotene (400 mg/d) (169) . This amount of Si-
carotene provides about three times the NRC recommendation. 
Prior to dryoff and after dryoff, neutrophils were isolated 
and incubated with 6-carotene, retinol, or RA. Phagocytic and 
killing indexes by neutrophils varied depending on in vivo 
treatment, in vitro treatment, and lactational status. The 
authors concluded that in vitro studies of neutrophil function 
must take into account the lactational state and vitamin 
status of experimental animals (169). 
Mononuclear leukocytes from the same experimental animals 
also were incubated with 6-carotene, retinol, or RA in the 
presence or absence of LPS (a B-cell mitogen) or Con A (170). 
In vitro DNA synthesis by Con A-stimulated MNL from cows 
receiving adequate vitamin A was inhibited by physiological 
concentrations of RA. The authors also reported that LPS-
stimulated DNA synthesis was inhibited by fl-carotene, retinol 
and RA. Additionally, they reported that DNA synthesis also 
was inhibited in cultures not stimulated with mitogen. 
Although not tested statistically, the values indicating DNA 
synthesis by LPS-stimulated MNL and those for unstimulated 
50 
cells do not differ to the 100-fold extent normally observed 
in DNA synthesis assays (50, 80). It was not reported whether 
numerical differences between LPS-stimulated cells and 
unstimulated cells were statistically different. Therefore, 
it is difficult to determine whether effects attributed to in 
vitro addition of vitamins are actually effects of the 
vitamins or a result of variation within the assay. 
A subsequent report by the same authors presented similar 
data (171). None of the treatments had a significant effect 
on phagocytic or killing indexes by neutrophils, however, R-
carotene supplementation tended (P<.07) to enhance the 
chemotactic index of neutrophils six weeks prior to dryoff. 
Additionally, there were no effects of vitamin supplementation 
on Con A- or LPS-stimulated DNA synthesis. Again, values for 
the LPS-stimulated assays were very low and no background 
values were reported (171). The authors concluded that "These 
data indicate that dietary 6-carotene stems the normal decline 
of serum vitamin A around dry off." (pg 1022) No data on serum 
concentrations of vitamin A precursors and metabolites were 
reported in the paper to support this conclusion. 
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PAPER I. PROLIFERATION AND PHENOTYPE OF BOVINE MONONUCLEAR 
LEUKOCYTES IN POKEWEED MITOGEN-STIMULATED CULTURES 
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ABSTRACT 
Peripheral blood mononuclear leukocytess from nulliparous 
Holsteins were used to evaluate pokeweed mitogen-induced 
changes in cell proliferation and phenotype in 2, 4, 6, 8, 10, 
12, and 14 d cultures. Cell numbers in unstimulated and 
stimulated (pokeweed mitogen, .08 fig/ml) 2 d cultures 
decreased to 45% of the number originally seeded. Cell 
numbers in pokeweed mitogen-stimulated cultures increased to 
96% of the number originally seeded by 6 d in culture and 
remained stable through 14 d of culture. In contrast, cell 
numbers in unstimulated cultures were lower from 4 to 14 d 
than mitogen-stimulated cultures, declining to 20% of the 
number originally seeded by 14 d. Analysis of cell types in 
pokeweed mitogen-stimulated cultures revealed that the 
increase in total cell numbers was attributable primarily to 
proliferation of CD4* T-cells. A concomitant increase in 
cells bearing activation antigens, IL-2 receptor and HHC class 
II antigen, also occurred in these cultures. The number of B-
cells increased between 2 d and 4 d, then remained fairly 
stable. Previous studies have shown that IgM production in 
pokeweed mitogen-stimulated cultures of bovine mononuclear 
leukocytes is 5 to 15 times greater than IgM production in 
nonstimulated cultures by 14 d after cultures are established. 
In conclusion, in vitro IgM production by pokeweed mitogen-
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stimulated B-cells is preceded by proliferation of T-helper 
(CD4*) cells and increased expression of activation markers. 
Key words: Polceweed mitogen, proliferation, phenotype, bovine 
leukocyte 
Abbreviations Used in This Paper: 
Con A = Concanavalin A 
HB88 = Hank's balanced salt solution 
LBT = Lymphocyte blast transformation 
MAb = Monoclonal antibody 
MNL = Mononuclear leukocyte 
NADC = National Animal Disease Center 
PHA = Phytohemagglutinin 
PWM-S = Pokeweed mitogen-stimulated 
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INTRODUCTION 
Mononuclear leukocyte (MNL) cell cultures are used to 
study lymphocyte mediated aspects of immune function in many 
species. Two commonly used in vitro approaches to evaluate 
MNL function are the lymphocyte blast transformation (LET) 
assay (2, 4, 10, 11, 16-18, 21, 33) and the Ig production 
assay (15, 20, 22-26, 29, 31, 32). The LET assay is 
considered an in vitro correlate for T lymphocyte-mediated 
immunity and the Ig-production assay is an in vitro correlate 
for B-cell function and humoral immunity. 
For the LET assay, MNL are isolated from animals and 
placed in cell culture for three to four days, followed by 
addition of [methyl-^H]thymidine (tritiated thymidine) . 
Incorporation of tritiated thymidine indicates the degree of 
DNA-synthesis and correlates well with lymphocyte 
proliferation (6). In general, greater DNA-synthesis in 
response to mitogenic or antigenic stimulation is considered 
an indicator of increased immune responsiveness whereas 
decreased DNA-synthesis is considered an indicator of 
immunosuppression. Mitogens commonly used to stimulate DNA-
synthesis in the LET assay are the plant lectins, concanavalin 
A (Con A), phytohemagglutinin (PEA), and pokeweed mitogen 
(PWM). Concanavalin A and PHA stimulate DNA-synthesis in 
murine T-cells and PWM has been shown to enhance DNA-synthesis 
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in MNL cultures from many species including bovine (27). 
For Ig-production assays, cultures of PWM-stimulated MNL 
are established. After 10 to 14 d incubations, supernatants 
are harvested and analyzed for concentrations of IgG or IgM 
using an enzyme-linked immunosorbent assay (ELI8A) (20, 22-25, 
32). Increases in Ig production are indicative of enhanced 
MNL responsiveness and of B-cell differentiation to Ig-
secreting cell-type. Decreased Ig production by the system 
suggests suppression of MNL functions supporting B-cell 
differentiation or direct negative effects on B-cell function. 
For both the LBT assay and the Ig production assay, 
alterations in the proliferation and phenotype of bovine MNL 
populations during culture have not been completely 
elucidated. Development of monoclonal antibodies (MAb) 
specific for cell surface molecules on bovine leukocytes has 
made it possible to use flow cytometry to characterize cell 
populations in bovine MNL cultures. 
The purpose of this study was to evaluate effects of PWM 
stimulation on the proliferation and differentiation of bovine 
MNL using MAb specific for bovine cells (3). Results 
presented are a compilation of data from studies used to 
determine effects of retinoids (19) or vitamin D analogs (22) 
on IgM production and cell phenotype in PWM-stimulated 
cultures of bovine leukocytes. For these data, results from 
control cultures for both studies were combined to provide a 
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better understanding of changes in cell phenotype culminating 
in MNL proliferation and IgM production by B-cells. 
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MATERIALS AMD METHODS 
Animals 
Eight female Holsteins were used as cell donors. Animals 
were approximately five years of age and had never been bred. 
The cattle were housed at the USDA, Agricultural Research 
Service, National Animal Disease Center (MADC), Ames, lA. 
They were fed a maintenance diet of pelleted ground corn cobs, 
wheat middlings, and corn, and had free access to water and 
hay or pasture. The animals were clinically normal throughout 
the experimental period. All animal related procedures were 
approved by the Institutional Animal Care and Use Committee of 
the NADC. 
Mononuclear Leukocyte isolation 
Mononuclear luekocytes were isolated using a previously 
described procedure (4). Briefly, blood was collected from 
the animals using jugular venipuncture. Acid citrate dextrose 
was used as an anticoagulant at a concentration of 10% 
vol/vol. Blood was centrifuged (1171 x g, 20 min, 21° C) and 
the buffy coat was harvested into Hank's balanced salt 
solution (BBSS, .015 mM without Ca2* and Mg2*, pH 7.2) at a 
concentration of 1 part buffy coat to 3 parts HBSS. Eight ml 
of diluted buffy coat was then overlayed onto 4 ml Percoll 
(specific gravity 1.084 g/cm?, Sigma Chemical Co., St. Louis, 
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MO) and centrifuged (450 x g, 40 min, 21' C) to separate MNL 
from red blood cells and polymorphonuclear leukocytes. 
Mononuclear leukocyte bands were collected and pooled by 
animal. Contaminating erythrocytes were lysed with hypotonic 
PBS and cell suspensions were centrifuged (650 x g, 10 min, 
21° C). Mononuclear leukocytes were subsequently washed with 
HBSS (650 X g, 10 min, 21' C), resuspended in RPMI-1640 medium 
(GIBCO Laboratories, Grand Island, NY), and counted (Celltrak-
3B automated cell counter. Angel Engineering Corp., Trumbull, 
CT). Mononuclear leukocyte suspensions were adjusted to 3.0 x 
10^ cells/ml. Based on flow cytometric analysis of propidium 
iodide uptake, viability of cells prepared by this method 
averaged 95%. 
Mononuolear Laukooyt* Cultures 
Cultures were established as described previously for 
evaluation of antibody production by PWM-stimulated cultures 
(19, 25). A representative study to determine optimal 
conditions (incubation period, cell density, and mitogen 
concentration) for the culture of MNL is presented in Table l. 
Five hundred nl of pokeweed mitogen in RPMI-1640 (.08 fig/ml 
final concentration) or RPMI-1640 only were added to 24-well 
tissue culture plates (CoStar, Cambridge, HA). Five hundred 
jul of RPMI-1640 containing fetal bovine serum (FBS, Hyclone 
Laboratories, Inc., Logan, UT) was added to each well 
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(providing 6.7% FBS in culture) followed by 500 nl of MNL in 
RPMI-1640 (providing 1.0 x 10*cells/ml in culture). Six 
identical wells (9 x 10* total cells) were seeded for each 
condition. Cultures that did not receive PWM are referred to 
as nonstimulated (control) cultures and cultures containing 
PWM are referred to as PWM-stimulated (PWM-8) cultures. 
Harvest of Mononuclear Leukocytes from cultures 
Cells were harvested from cultures at 2 d intervals from 
2 to 14 d. Tissue culture plates were centrifuged (650 x g, 
10 min, 4" C) and the supernatant was carefully removed to 
prevent cell loss. Cold trypsin (.05% in versene) was added 
and allowed to sit for 5 min to detach adherent cells from the 
plastic. The MNL and trypsin mixture was transferred 
immediately to plastic tubes containing 100 ul FBS to 
inactivate trypsin. Tissue culture plates and tubes were kept 
on ice throughout the cell recovery procedure. Identically 
stimulated cultures were pooled by animal. Cells from, two or 
more animals in nonstimulated wells were pooled when necessary 
to assure sufficient numbers for analysis. MNL preparations 
were centrifuged (650 x g, 5 min, 4* C), supernatants were 
removed and cells were resuspended in HESS containing .1% NaNj 
and 1% FBS (first wash buffer). Cells were washed (250 x g, 
20 min, 4* C), to remove contaminating platelets and debris, 
and the supernatant was aspirated. Washed cells were 
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resuspended in 1st wash buffer, counted, and adjusted to a 
concentration of 4 x lo' cells/ml. 
Flow Cytometric Analysis 
Mouse anti-bovine primary antibodies, specific for bovine 
leukocyte antigens, were from VMRD Inc. (Pullman, WA) and are 
listed in Table 2. Isotype-specific goat anti-mouse secondary 
antibodies, conjugated with fluorescein isothiocyanate (FITC), 
were purchased from Organon Teknika-Cappel (Durham, NC). 
Approximately 2 x 10® MNL in 50 fil of 1st wash buffer were 
added 96-well U-bottom plates (Costar, Cambridge, MA), 
followed by 50 nl (1:150 dilution in first wash buffer) of 
primary MAb or 50 /xl of first wash buffer in control wells. 
Negative controls consisted of MNL without primary or 
secondary antibody and MNL with secondary antibody only. 
Nonspecific binding of MAb was tested using mouse ascites 
fluid at 1:50 dilution in first wash buffer and did not differ 
from background. For this reason, this control was not 
included in the present study. Cells were incubated for 3 0  
min on ice, then washed (1171 x g, 2 min, 4* C) twice with 
first wash buffer. A Miniwash plate washer (Dynatech 
Laboratories, Inc., Alexandria, VA) was used to aspirate 
supernatant and add buffer. Fifty nl of first wash buffer was 
added to the wells after the last wash, followed by 50 fil 
(1:500 dilutions in first wash buffer) of isotype specific 
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secondary antibody. Cells were incubated on ice, in the dark, 
for 30 min and subsequently washed 3 times with second wash 
buffer (BBSS containing .1% NaN^). 
Analysis of Cell Phenotyp* in Culture 
Approximately 5000 cells that exhibited forward and side 
light scattering properties consistent with bovine MNL were 
analyzed per sample using a flow cytometer (Becton Dickinson 
FACScan, Becton Dickinson Immunocytometry Systems, San Jose, 
CA). The argon laser in the flow cytometer emitted an 
excitation wavelength of 480 nm. Cells bearing a FITC 
conjugated secondary antibody emitted fluorescence detected by 
a 530 nm bandpass filter. Log of fluorescence intensity was 
analyzed by histogram. Markers were set to provide an average 
background fluorescence of 2.5% in negative controls, and 
these settings were maintained at the same position for all 
samples. Data from the flow cytometric analysis were 
expressed as percent of cells from a sample bearing a 
particular cell marker or as actual cell numbers bearing a 
specific cell marker. 
statistical Analysis 
Results are means of eight animals tested on at least 
four different occasions. Student's t-test was used to 
determine differences. 
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RESULTS AND DISCUSSION 
Cell Proliferation in Culture 
Two d after cell cultures were established, cell numbers 
in the control and PWM-S cultures were approximately equal. 
Numbers in both cultures had declined at 48 h to less than 45% 
of the number originally used to seed the cultures (Figure 1). 
Even though cell viability generally was greater than 90% at 
the time of seeding, the reduction in cell numbers indicated a 
large proportion of cells may have been damaged during the 
isolation and seeding procedures. Mitogen-stimulated cultures 
harvested 4 and 6 d after seeding had greater (P<.01) cell 
numbers compared to 2 d control and PWM-S cultures and 4 d 
control cultures. Pokeweed mitogen-stimulated cultures 
harvested at 4 and 6 d contained 72 and 96%, respectively, of 
the number originally seeded. Cell numbers in PWM-S cultures 
were not different among cultures harvested from 6 d through 
14 d (P<.01). By 12 d in culture, cell numbers in control 
cultures had decreased (P<.01) to less than 20% of the number 
originally seeded whereas cell numbers in PWM-S cultures 
peaked on 12 d at 116% of the number originally seeded. 
In LBT assays, mitogen-stimulated DNA-synthesis peaks 
by 4 d in cultures (11, 26). Human lymphocytes have a cell 
cycle that ranges in duration from 10 to 25 h and other 
species do not differ greatly (11). Therefore, cell division 
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resulting in peak proliferation should occur in the LBT assay 
within a few hours after peak DNA synthesis, or within 5 d in 
culture. Cells in PWM-S MNL cultures in the present study 
actively proliferated between 2 and 6 d in culture with peak 
proliferation having occurred by 6 d. These results confirm 
the LBT assay as a measure of proliferation of bovine 
lymphocytes. Based on proliferation results in the present 
study, DNA synthesis measured by the LBT asssay is a good 
indicator of proliferation of bovine MNL. 
Alteration of Call Phenotypa in Culture 
Representative dot plots of bovine cells from PWM-S and 
control cultures are presented in Figures 2A and 2B, 
respectively. A dot plot of freshly isolated, blood 
leukocytes from a cell donor used in the study is shown in 
Figure 2C. Forward-scatter light incidence, indicative of 
size, is on the horizontal axis, whereas side-scatter light 
incidence, indicative of granularity, is on the vertical axis. 
Cells in region 1 on the plots were judged to be MNL based on 
size and granularity. Cells from control cultures had light 
scatter characteristics similar to freshly isolated peripheral 
blood leukocytes, whereas cells from PWM-S cultures were 
larger and associated with more debris. Debris in the PWM-S 
cultures may be a result of greater cell death even though the 
number of cells actually increased. The larger size of cells 
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in the PWM-S cultures is probably a result of cell activation. 
Objects outside region 1 of the PWM-S cultures did not 
exhibit light scattering properties characteristic of MNL 
(Figure 2A). Further analysis of objects in this region 
revealed that all markers tested bound nonspecifically (data 
not shown). Based on the degree of nonspecific binding and 
the lack of typical light scattering properties for MNL, cells 
outside region 1 were excluded from analysis of cell 
populations. Cells outside region 1 likely are dead and dying 
cells although this was not confirmed by other methods. 
Cell phenotype data are presented as actual number of the 
cell type recovered. The contributions of each cell-type to 
the MNL population used to seed the cultures are shown as time 
0 values in Figures 3 through 5. These values represent 
averages of 11 to 14 separate days of sampling for the eight 
animals used in the study. The marker for monocyte/macrophage 
cells used in this study did not bind appropriately based on 
research conducted at a later date with a MAb from a different 
hybridoma cell line (data not shown). Therefore, percentages 
of monocyte/macrophage cells reported may be lower than were 
actually present in the samples. 
Numbers of specific cell types harvested from cultures 
were affected by PWM-stimulation. The increase in cell 
numbers observed from 4 and 6 d harvests could be attributed 
mainly to proliferation of CD2* T-cells (Figure 3A). Numbers 
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of CD2* cells in PWM-S cultures increased from 500,000 in 2 d 
cultures to 2.75 million in 6 d cultures, whereas CD2* cell 
numbers declined slightly in parallel control cultures. The 
proportion of CD2* cells in PWM-S cultures at 6 d was 
approximately 60%. similar results were obtained by Olobo and 
Black (26). They reported a range of 25-56% T cells in 
similar PWM-stimulated cultures of bovine mononuclear cells 
from Bos indicus cattle over a 7 d period of incubation. The 
lower percentage of T cells reported by Olobo and Black (26) 
may have been because of differences in age and breed of 
cattle (11). In both studies, T-cells were the predominant 
cell type in PWM-S cell cultures after 4 d. 
The total T-cell population is comprised of several 
subpopulations based on functional and phenotypic properties. 
Cell-surface expression of CD4 or CD8 molecules defines two 
distinctly different subpopulations of T-cells. The CD4* T-
cells are considered helper/inducer cells and CD8* T-cells are 
considered suppressor/cytotoxic cells (34). Division of 
bovine T-cells into these two functionally distinct 
subpopulations has been documented (15). DNA-synthesis by 
PWM-stimulated MNL was decreased when CD4* cells were depleted 
from the cell population wheras addition of CD4* cells to 
depleted populations restored PWM-induced DNA-synthesis in a 
dose dependent manner (15). In contrast, PWM-induced DNA-
synthesis was greater when CD8* cells were absent from 
67 
cultures (15). Addition of CD8* cells to depleted MNL 
cultures resulted in a dose-dependent decrease in DNA-
synthesis. 
In the present study, the increase in CD2* cell numbers 
in PWM-S cultures was attributable primarily to an increase in 
CD4* cells (Figure 3B). Previous studies have shown that 
bovine MNL cultured under identical conditions of PWM-
stimulation and harvested at 14 d, secrete 5 to 15 fold as 
much IgM as nonstimulated cultures (23, 25). Because the PWM-
S cultures in the present study were established in a manner 
identical to PWM-S cultures established for IgM production, 
the increase in number of CD4* cells supports their role as 
the helper/inducer subpopulation of T cells in PWM-S cultures. 
Actual numbers of CDS* cells in PWM-S cultures remained 
fairly constant (Figure 3C) but were greater in 4 - 14 d PWM-S 
cultures compared to control cultures harvested on the same 
days. As a result of proliferation of CD4* CDS* 
represented a smaller proportion of the total cell population 
in PWM-S cultures compared to control cultures on 10 d and 12 
d (P<.01). 
Actual numbers of B-cells increased from 500,000 cells in 
2 d PWM-S cultures to approximately 1.25 million cells in 4 d 
cultures, and had declined to 1 million cells in 6 d cultures 
(Figure 4). The number of B-cells in 6 d PWM-S cultures 
increased 2 fold compared to 2 d cultures. In contrast, the 
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number of CD4* cells in 6 d PWM-S cultures increased 7 fold 
compared to 2 d cultures (Figure 3B). Therefore, the major 
MNL subpopulation undergoing proliferation in PWM-S cultures 
is the CD4* population. Lutje and Black (1992) (15) prepared 
parallel PWM-S cultures of unseparated MNL and separated B-
cells. The B-cell cultures also were supplemented with T-cell 
growth factors in supernatants harvested from Con A-stimulated 
cultures of bovine MNL. They found DNA-synthesis in PWM-S 
cultures of isolated B-cells was 20% that of PWM-S cultures of 
unseparated MNL. Therefore, although B-cells differentiate 
into Ig secreting cells in PWM-S cultures, they are not the 
major cell-type undergoing proliferation. The increase in 
CD4* cells likely is responsible for promotion of B-cell 
differentiation. 
A bovine plasma cell marker was not available at the time 
of the study, therefore, the degree of differentiation of B-
cells into plasma cells is not known. Human B-cells 
stimulated by PWM do not fully differentiate into plasma cells 
even though IgM secretion increases significantly (P. E. 
Lipsky, personal communication). Instead, PWM-induced IgM 
secretion is from immunoglobulin secreting cells which still 
can undergo cell division (8, 9). Zola (35) and Ling (14) 
reported that differentiated plasma cells may retain surface 
immunoglobulin. It is not known if IgM secretion by PWM-S 
bovine MNL is produced by B-cells or fully differentiated 
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plasma cells. Secretion of IgG was not enhanced in PWM-S 
cultures of bovine MNL (data not shown) indicating that class-
switching does not occur. Therefore, differentiation of 
bovine B-cells into plasma cells in PWM-S cultures probably 
does not occur. 
At time 0, 7.2 x lo' (approximately 80%) of the cells 
originally added to cultures expressed the MHC class II 
antigen (Table 3). This value is higher than the range of 9 
to 52% for bovine peripheral blood MNL reported by Lalor et 
al. (1986) (12). It is unknown why these differences exist. 
By 2 d in culture, the number of cells expressing the MHC 
class II antigen had decreased to approximately 1.8 x 10* 
cells (45% of cells harvested) and 2.5 x 10* cells (62% of 
cells harvested in control and PWM-S cultures, respectively 
(Table 3). In 4 d cultures, number of cells expressing the 
MHC Class II antigen had increased (P < .01) to almost 5 x 10* 
or approximately 74% of the cells harvested from PWM-S 
cultures (Table 3). Number of cells expressing the MHC class 
II antigen continued to increased through 6 d in culture, then 
remained fairly constant. 
The MHC class II antigen is expressed constitutively on 
bovine B-cells and monocytes in isolated MNL (12). 
Additionally, the MHC class II antigen is expressed on 
activated T-cells in bovine (12) and several other species 
except mice (5). The increase in the number of cells 
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harvested from PWM-S cultures of bovine MNL that expressed the 
MHC class II antigen was concomitant with an increase in the 
number of CD4* cells. B-cells in the PWM-S cultures did not 
proliferate enough to account for the increase in cells 
bearing the MHC class II antigen. Therefore, the MHC class ii 
antigen was probably expressed on the CD4* cells undergoing 
proliferation, indicating that this subpopulation of T-cells 
was activated. 
Expression of the IL-2 receptor (IL-2R) is an indicator 
of T-cell activation (1, 13, 30). In the present study, the 
number of cells bearing IL-2R in PWM-S cultures increased from 
2 to 8 d and were greater than in control cultures for all 
days (Table 3, P<.01). These results agree with studies with 
human T-cells in which IL-2 provides a necessary signal for 
induction of proliferation and upregulates IL-2R expression 
(1). Because the percent and number of IL-2R* cells were 
greater than percent and number of CD4* cells in 2 to 8 d PWM-
s cultures, it is likely that other cells were induced to 
express the IL-2R. Further studies using 2-color flow 
cytometry would clarify the types of cells that are induced to 
express IL-2R after PWM stimulation. Null cells are a 
population of leukocytes that do not express markers for T-
cells or B-cells. The role of null cells in cattle is not 
completely understood (28). Studies indicating null cells are 
present in greater numbers in bovine neonates and young calves 
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than in mature cattle, and that they localize in the 
epithelium of the small intestine, suggest that null cells may 
be involved in mucosal Immunity (28). In PWM-S cultures, 
numbers of null cells gradually increased from 4 d through 14 
d and were significantly greater than null cell numbers in 
control cultures during the same time period (Figure 5}. The 
effect of null cells on other cell populations in bovine MNL 
cultures is not known. However, in vivo depletion of null 
cells from calves resulted in greater in vivo Ig production 
and greater response to PWM in vitro (7). Further research is 
needed to understand the significance of null cell 
proliferation in PWM-S cultures and the in vivo role of null 
cells in cattle. 
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CONCLUSIONS 
Proliferation and differentiation of bovine MNL in 
culture was altered by PWM stimulation. Numbers of cells in 
PWM-S cultures were 60 and 150% greater in 4 and 6 d cultures 
than in 2 d cultures. Most of the increase in cell numbers 
was attributable to proliferation of CD4* cells and a 
concomitant increase in cells expressing activation antigens, 
IL-2R and the MHO Class II antigen. B-cell numbers increased 
in 2 d and 4 d cultures, but were fairly stable for the 
remaining period. In conclusion, PWM-stimulated 
differentiation of B-cells into IgM secreting cells is 
accompanied by proliferation of CD4* cells, and an early 
increase in cells bearing activation antigens. Therefore, PWM 
is a T-helper cell mitogen in cultures of bovine MNL. These 
results suggest that CD4+ T-cells play an important role in 
activation of B-cells in bovine PWM-S cultures, possibly 
through elaboration of lymphokines promoting B-cell 
differentiation into IgM-secreting cells. Further research is 
needed to determine which cells are stimulated to express the 
activation markers in the bovine system. Additionally, the 
extent to which B-cells differentiate into plasma cells and 
the role of null cell proliferation in culture reguires 
further investigation. 
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TABLE 1. Determination of optimal conditions for pokeweed 
mitogen (PWM) stimulation of bovine mononuclear leukocytes 
using three PWM concentrations, three cell concentrations, 
and three incubation times. 
Cells 
(XlO"^) 
PWM 
(Mg/ml) 
Incubation Time 
6 10 14 
.5 0 2.9 ± .1 3.0 ± .1 3.1 ± .02 
.027 4.6 ± .5 6.0 ± .9 7.1 ± 1.0 
. 08 4.5 ± .5 6.2 ± .8 7.8 ± .9 
.24 4.9 ± .5 6.6 ± 1.0 8.1 ± 1.0 
1.0 0 2.9 ± .1 3.0 ± .04 3.1 ± .04 
.027 6.4 ± .5 7.8 ± .6 8.6 ± .6 
.08 6.8 ± .5 7.8 ± .6 8.5 ± .6 
.24 6.8 ± .5 7.5 ± .6 7.8 ± .7 
2.0 0 2.9 ± .1 3.0 ± .1 3.2 ± .1 
.027 4.5 ± .4 5.2 ± .6 5.5 ± .7 
.08 4.2 ± .4 4.6 ± .4 5.0 ± .5 
.24 4.4 ± .4 4.6 ± .4 4.8 ± .4 
^ Conditions used for IgM production assay were .08 ng/ral 
of PWM and 1.0 X 10^ cells/ml with 14 d incubations. 
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TABLE 2. Monoclonal antibodies used in flow cytometric 
analysis of leukocyte antigen expression. 
Specificity MAb designation ig isotype 
CD2 (Pan T) BAQ95A IgG^ 
CDS (^Tcytotoxic/suppressor) CACT80C IgGi 
CD4 (Thgipgr/inducer) GC501A igM 
B-cell (B2) BAQ44A IgM 
Macrophage (M2) CH137A IgM 
Null cells (N2) BAQ4A IgGi 
Interleukin-2 receptor (ACTS) CACT116A IgGi 
MHC class II TH14B igGg 
^ Monoclonal antibodies from VMRD, Inc., Pullman, WA. 
TABIiE 3. Number of cells (x 10*^) bearing activation antigens in unstimulated and 
pokeweed mitogen (PWH)-stimulated cultures of bovine mononuclear leukocytes^. 
Incubation Time (d) 
Marker Mitogen 0 2 4 6 8 -14 
MHC Class II None 7.1 + .3"' 1.8 ± .l" 1.3 ± .l" 1.2 ± .l"* .6 
o
 
+1 
PWM 7.1 ± .3" 2.5 ± .l" 4.7 ± .5' 6.0 + .3'" 
CO in 
± .2" 
IL-2 Receptor None 1.7 ± .1' 
o
 
H
 ± .2" .7 ± .4 ± .OSf .3 1+
 
o
 
PWM 1.7 ± .1' 2.0 ± .2' 3.7 ± .4" 6.5 ± .4® 6.7 1+
 
^ Six wells of identical cultures were established initially containing a total of 
9.0 X 10^ cells. 
Within a row, means with different superscripts differ (P<.01). 
4 6 8 10 12 14 
Incubation Time (d) 
Figure 1. Proliferation of bovine mononuclear leukocytes in control (unstimulated 
solid bars) and pokeweed mitogen-stimulated (.08 tig/ml, hatched bars) cultures. 
Number of cells in culture were determined at 48-h intervals for 14 d. Values 
represent means of 8 animals sampled 4 times. For pokeweed mitogen-stimulated 
cultures, means with different letters differ (P<.01). 
Figure 2. Representative dot plots from flow cytometric 
analysis of cultured bovine mononuclear leukocytes stimulated 
with pokeweed mitogen (2A) or unstimulated (2B). The dot plot 
in 2C is representative of a whole blood analysis. 
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Figure 3. Cell type of bovine mononuclear leukocytes in 
control (unstimulated, solid lines) and pokeweed mitogen-
stimulated (.08 /xg/ral, dashed lines) cultures. Number of 
cells in cultures were determined at 48-h intervals for 14 d. 
Values represent means of 8 animals sampled 4 times. Cell 
numbers were greater (P<.01) for each cell type in pokeweed 
mitogen-stimulated cultures from 4 d through 14 d. 
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Figure 4. Numbers of B-cells in control (unstimulated, solid 
lines) and pokeweed mitogen-stimulated (.08 ng/ml, dashed 
lines) cultures of bovine mononuclear leukocytes. Numbers of 
cells in cultures were determined at 48-h intervals for 14 d. 
Values represent means of 8 animals sampled 4 times. Cell 
numbers were greater (P<.01) in pokeweed mitogen-stimulated 
cultures from 4 d through 14 d. 
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Figure 5. Numbers of null cells in control (unstimulated, 
solid lines) and pokeweed mitogen-stimulated (.08 Mg/ml, 
dashed lines) cultures of bovine mononuclear leukocytes. 
Numbers of cells in cultures were determined at 48-h intervals 
for 14 d. Values represent means of 8 animals sampled 4 
times. Cell numbers were greater (P<.01) in pokeweed mitogen-
stimulated cultures from 4 d through 14 d. 
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ABSTRACT 
Eight Holstein females were used to evaluate effects of 
13-cis-retinoic acid administration on plasma concentrations 
of vitamins (retinoic acid isomers, retinol, fl-carotene, and 
a-tocopherol) and on immune function. Treatments were 0 
(vehicle only), 100, 200, or 400 mg 13-cis-retinoic acid/day 
for seven days. Retinoic acid was dissolved in dimethyl 
sulfoxide and injected intramuscularly. Treatment with 13-
cis-retinoic acid elevated plasma concentrations of 13-cis-, 
all-trans-, and 9-cis-retinoic acids in a dose dependent 
manner. Plasma concentrations of retinol, B-carotene, and a-
tocopherol were unaffected by treatment. Lymphocyte function, 
as determined by in vitro response to mitogenic stimulation, 
was not affected by in vivo administration of 13-cis-retinoic 
acid. However, in vitro supplementation with 13-cis-retinoic 
acid of unstimulated and mitogen-stimulated cultures of 
mononuclear leukocytes from all treatment groups inhibited 
proliferation relative to cultures not supplemented with 13-
cis-retinoic acid. Results indicate supplementation of cattle 
with 13-cis-retinoic acid is a viable means of altering plasma 
concentrations of retinoic acid isomers. Although in vivo 
supplementation did not alter lymphocyte responses to 
mitogens, in vitro supplementation inhibited proliferation. 
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Abbreviations Used in this Paper: 
Con A = Concanavalin A 
DM80 = Dimethyl sulfoxide 
PBS = Fetal bovine serum 
HBSS = Hank's balanced salt solution 
IS = Internal standard 
MNL = Mononuclear leukocyte 
PWM = Pokeweed mitogen 
13-Cis-RA = 13-Cis-retinoic acid 
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INTRODUCTION 
Vitamin A is an essential nutrient for growth, bone 
formation, vision, and reproduction. Vitamin A also has been 
shown to be essential for optimal function of the immune 
system. Animals deficient in vitamin A have depressed natural 
killer cell activity, decreased antibody production, decreased 
responsiveness of lymphocytes to mitogenic stimulation, and 
increased susceptibility to infection (40). Supplementation 
with vitamin A has been found to enhance immunoglobulin 
production, cytotoxic activity, and graft-versus-host 
responses (40). 
Dairy cows and their calves are more susceptible to 
infection during the periparturient period. New intramammary 
infections in dairy cows are prevalent during the last two 
weeks prior to parturition and often become apparent during 
the first week following parturition (38, 43). Calves are 
susceptible to disease causing organisms resulting in 
respiratory and enteric infections (32). Immune function in 
dairy cattle is suppressed during the periparturient period as 
evidenced by lower DNA synthesis of mononuclear leukocytes 
(MNL) in response to mitogens (6, 23) and decreased neutrophil 
function (24). Cows (18, 26) and calves (2) often can be 
described as having a marginal vitamin A status (<200 ng/ml 
vitamin A in plasma [34]) during this period of increased 
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susceptibility to infection. Hepatic stores of vitamin A in 
calves also are typically low (5). 
Low vitamin A status in cows has been associated with 
increased somatic cell counts in milk, an indication of 
intramammary infection (7, 21). Cows with somatic cell counts 
greater than 500,000 cells/ml had lower plasma concentrations 
of vitamin A than cows with somatic cell counts less than 
500,000 cells/ml (7,21). Investigations of effects of 
supplementation with vitamin A or its precursor, B-carotene, 
on new intramammary infections of cows during the 
periparturient period have produced contradictory results (8, 
13, 37). Chew and coworkers (8, 13) found dietary vitamin A 
(retinyl palmitate) and fl-carotene supplementation had 
beneficial effects on udder health. In contrast, Oldham et 
al. (37) found no effect of dietary vitamin A (retinyl 
acetate) and B-carotene supplementation on udder health but 
milk production increased. 
Isomers of retinol and retinoic acid (RA) were shown to. 
enhance in vitro IgM production by polyclonally stimulated 
bovine MNL, however, the RA isomers were more potent than 
retinol isomers in this regard (36). 13-Cis-retinoic acid 
(13-ois-RA) has recently been shown to Inhibit in vitro 
proliferation of bovine CD4+ T-cells and expression of 
activation antigens, IL-2 receptor and MHC class II antigen 
(35). These results suggest 13-cis-RA Influences events 
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associated with T-cell activation and B-cell function. 
The purpose of the present study was to determine effects 
of administration of vitamin A, in the form of 13-cis-RA, on 
plasma concentrations of vitamins and mitogen stimulated 
proliferation of MNL in vitro. Retinoic acid was chosen as 
the form of vitamin A to administer because it is the form 
which has been shown to be active in affecting immune function 
in other species (10, 41, 42). The isomer, 13-cis-RA, was 
used because it is readily converted to all-trans RA (30), is 
less toxic than all-trans RA, and has a longer half-life in 
vivo which provides a pool for isomerization to all-trans RA 
(14). Also, 13-cis-RA previously was shown to enhance in 
vitro IgM production by bovine B-cells (35). 
r 
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MATERIALS AND METHODS 
Animals and Treatments 
Eight female Holsteins were used in three replicate 
experiments evaluating effects of administration of 13-cis-RA 
on plasma concentrations of vitamins and general immune 
function. The experiments were conducted between May 27, 1992 
and October 9, 1992. Animals were approximately five years in 
age and had never been bred. Cattle were housed at the USDA, 
Agricultural Research Service, National Disease Center, Ames, 
lA. They were fed a maintenance diet of pelleted corn cobs, 
wheat middlings, and corn and had free access to water and hay 
or pasture. Animal related procedures were approved by the 
Institutional Animal Care and Use Committee of the National 
Animal Disease Center. 
Treatments were vehicle only (DMSG), 100, 200, or 400 mg 
13-cis-RA/d for seven consecutive days. Animals were randomly 
assigned to treatments prior to the beginning of each 
experimental period. Experimental periods lasted 
approximately 4 wk and treatments were administered during the 
second week. Animals were bled on -5, -3, and 0 d (prior to 
initiation of treatments) to establish baseline values for 
plasma concentrations of vitamins and responsiveness (as 
indicated by increased DNA synthesis) of MNL to mitogenic 
stimulation. Plasma samples for analysis of vitamin 
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concentrations were obtained daily from 0 - 18 d. Mononuclear 
leukocytes for blastogenesls (DNA-synthesis) assays were 
obtained on 1-4, 7-11, 14, 16, and 18 d. Time between 
experimental periods was 2.5 wk between the first and second 
experiments and 6.5 wk between the second and third 
experiments. 
Plasma Collection 
Blood was collected by jugular venipuncture into 
heparinized vacutainer tubes and immediately placed in the 
dark. Blood was centrifuged (20 min, 1171 x g, 21° C). 
Plasma was collected under yellow light and stored at -20° c. 
All plasma samples from one animal in one experiment were 
analysed together for RA isomer concentrations and B-carotene, 
retinol, and a-tocopherol concentrations. 
Vitamin Analysis by HPLC 
Concentrations of RA Isomers in plasma samples were 
determined using a modification of a previously described 
method (33). Briefly, 2 ml plasma was placed into 18 x 150 
glass tubes and 50 fil of RA as an Internal standard (IS) were 
added to samples and to standard tubes. Two ml of sodium 
hydroxide (.025 N) in ethanol were added to the samples and 
samples were vortexed. The alkaline solution was extracted 
twice by adding 4 ml hexane and subsequently discarding the 
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upper phase. One-half ml of 4 N HCl was added to samples and 
the mixture was vortexed four times. Hexane (6 ml) was added 
and samples were vortexed. Samples were allowed to sit until 
the phases separated. The upper phase was collected and dried 
under nitrogen. The standard curve was prepared and the 
samples were run using HPLC performed with normal phase 
columns. The column (.46 x 15 cm) for detection of RA isomers 
was an Alltech Silica Column (3 /xm) . Two columns were used in 
tandem. Samples were read at 340 nm. 
Concentrations of 6-carotene, retinol, and a-tocopherol 
in plasma were determined using a modification of a previously 
described method (22). Two hundred til of plasma and 200 jul of 
ethanol containing the IS were placed in a 13 x 100 glass 
tube. Eight tubes were prepared with IS only to use for the 
standard curve. Samples were vortexed, 1.5 ml hexane was 
added, and samples were vortexed again. The upper phase 
containing the vitamins was removed after phases separated, 
and the upper phase was dryed under nitrogen. Chloroform (25 
Ml) was added to the samples and allowed to sit for 15 min. 
Samples were diluted by addition of 125 fil of column solvent 
(78% acetonitrile, 14% chloroform, 3.5% isopropenol, and 4.5% 
water). Standards of all-trans retinol, B-carotene, and a-
tocopherol (Kodak Laboratory Chemicals) were prepared. 
Samples were run using HPLC with reverse phase columns. The 
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columnn (.46 x 15 cm) for detection of 6-carotene, retinol, 
and a-tocopherol was an Alltech Econosphere Column (3 /xm) . 
Mononuclear Leukocyte Isolation for Blastogenesis Assays 
Mononuclear leukocytes were isolated using a previously 
described procedure (15). Briefly, blood was collected from 
animals using jugular venipuncture. Acid citrate dextrose as 
an anticoagulant and provided 10% of the volume. Blood was 
centrifuged (20 min, 1171 x g, 21' C) and the mononuclear 
layer was collected into 50 ml conical tubes containing Hank's 
balanced salt solution (HB88, pH 7.2, 0.015 mol/L) without 
Ca2+ or Mg2+. Eight ml of the mixture was gently overlayed 
onto 4 ml Percoll gradient solution (specific gravity 1.084 
g/cm3, Sigma Chemical Co., St. Louis, MO) and centrifuged (40 
min, 450 X g, 21* C). Mononuclear leukocytes at the interface 
of Percoll and plasma were collected and pooled by animal. 
Contaminating erythrocytes were removed by hypotonic lysis. 
After centrifugation (10 min, 650 x g, 21* C), the MNL were 
washed in HBSS (10 min, 650 x g, 21* C), resuspended in RPMI-
1640 medium (Gibco Laboratories, Grand Island, NY), and 
counted (Celltrak-3B automated cell counter. Angel Engineering 
Corp., Trumbull, CT). Cell concentrations were adjusted to 2 
X 10^ cells/ml. Cell viability was typically greater than 95% 
based on flow cytometric analysis of propidium iodide uptake. 
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Mononuclear Leukocyte Cultures 
Mononuclear leukocyte cultures were established for 
evaluation of lymphocyte responsiveness to mitogenic 
stimulation. Three concentrations each of concanavalin A (Con 
A; 3.9, 7.8, and 15.6 (tg/ml of culture) and pokeweed mitogen 
(PNM; .08, .4, and 2.0 ng/ml of culture) (Sigma Chemical Co.) 
were prepared in RPMI-1640 containing 13.4% heat-inactivated 
fetal bovine serum (FB8, Hyclone Laboratories, Inc. Logan, 
UT). Concentrations of mitogens were chosen, based on prior 
testing, to encompass the concentration providing optimal 
response. Mitogens (ioo nl) were added to wells of 96-well 
microtiter plates (CoStar, Cambridge, MA) followed by 100 iil 
of MNL. Parallel cultures without mitogen (unstimulated) were 
also established. Six wells per mitogen concentration were 
prepared for each animal. Cultures received an additional 10 
/xl of serum containing 13-cis-RA (solubilized in 100% HPLC-
grade ethanol) to provide a concentration of 10* M 13-cis-RA 
in culture or 10 /il of serum as controls. The concentration 
of serum in culture was 11% and did not contain detectable 
retinol. 
Mononuclear leukocyte cultures were incubated in 
humidified 5% C02 atmosphere at 39" C for 90 h. Cultures were 
pulsed with 18.5 KBq of [methyl~3H]thymidine (Amersham 
Corporation, Arlington Heights, IL) in 50 fxl of RPMI-1640 
medium during the last 18 h. Mononuclear leukocytes were 
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harvested (PHD harvester, Cambridge Technology, Watertown, MA) 
onto glass fiber filters. Retained radioactivity, expressed 
as counts per minute (cpm) was determined by liquid 
scintillation spectrophotometry (LS8000, Beckman Instruments, 
Inc., Fullerton, CA). 
Mononuclear Leukocyte Isolation for Determination of 
Intracellular Retinoic Acid Concentrations 
Mononuclear leukocytes were isolated as described in the 
previous section with some modifications. Blood was collected 
into 250 cc bottles and centrifuged (20 min, 1171 x g, 21° C). 
The MNL layer was collected, the whole blood was centrifuged 
again (20 min, 1171 x g, 21* C), and the MNL layer was 
collected a second time to improve yield of MNL. The MNL 
layer was divided into two 250 cc bottles and contaminating 
erythrocytes were removed by two successive lysing procedures. 
The MNL pellet was subsequently resuspended in HESS and 
transferred to 15 ml conical tubes. Cells were counted and 
the total volume was recorded. Cell suspensions were 
centrifuged (10 min, 650 x g, 21" C), supernatants were 
removed, and MNL pellets were stored at -80' C. Appropriate 
samples from experimental animals were thawed and pooled on 
the day of HPLC analysis for RA isomer concentrations. Cells 
were lysed by addition of water followed by sonication (3x) 
for 10 sec bursts with cooling between bursts. Retinoic acid 
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isomers (13-cis, all-trans, and 9-cis) were extracted using 
the procedure as described for plasma extraction and their 
concentration determined by HPLC. 
Statistioal Analysis 
An ANOVA was performed on data for plasma concentrations 
and lymphocyte blastogenesis assays. Where differences in 
means were detected, means were further analyzed by the method 
of least significant difference. Data from plasma analyses 
were divided into pretreatment (-5, -3, and 0 d), treatment (1 
through 6 d), posttreatment I (7 through 12 d), and 
posttreatment II (13 through 18 d) periods. Because there 
were fewer sampling points for the DNA synthesis assay, data 
from DNA synthesis assays were divided into three time periods 
of pretreatment (-5, -3, and 0 d), treatment (1 through 4 and 
7 d), and posttreatment (8 through 11, 14, 16, and 18 d). 
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RESULTS AND DISCUSSION 
Plasma Conoantratlons of Retlnoio Aoid Isomers 
Plasma concentrations of 13-cis, all-trans, and 9-cis RA 
increased (P=.0001, P=.0333, and P=.0074 respectively) in a 
dose dependent manner in treated animals (Figure 1). 13-cis-
RA was elevated to the greatest extent (Figure lA). The mean 
plasma concentration of 13-cis-RA in animals receiving 400 mg 
13-cis-RA/d was approximately 10 fold greater in posttreatment 
period I compared to pretreatment plasma concentrations or 
plasma concentrations in animals not treated with 13-cis-RA. 
Plasma concentrations of 13-cis-RA in animals receiving 
100 mg 13-cis-RA/d, peaked during the treatment period (Figure 
lA). The mean plasma concentrations of 13-cis-RA were 
approximately equal for both the treatment period and 
posttreatment period I in animals receiving 200 mg 13-cis-RA. 
However, animals receiving 400 mg 13-cis-RA had a greater mean 
plasma concentration of 13-cis-RA during posttreatment period 
I than during the treatment period. This may indicate that as 
the plasma concentration of 13-cis-RA increases, the 
isomerization rate does not increase. 
The same trend was evident for plasma concentrations of 
all-trans RA (Figure IB). However, plasma concentrations of 
all-trans RA were not elevated to the same extent as plasma 
concentrations of 13-cis-RA. The maximum concentration of 
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all-trans RA in animals receiving 400 mg 13-cis-RA was 
approximately 6 fold greater than baseline values for the same 
animals or plasma concentrations of all-trans RA in control 
animals (Figure IB). 
Plasma concentration of 9-cis RA was elevated 
significantly (P=.0074) but to a lesser extent than 13-cis-and 
all-trans RA concentrations in treated animals (Figure IC). 
The RA isomer, 9-cis RA, is the major ligand for retinoid-X-
receptor (RXR) (20, 29) whereas all-trans-RA is the primary 
ligand of the RA receptor (RAR) (17, 39, 48). The RXR can 
form a homodimer or a heterodimer with (RAR) or other 
steroid/hormone receptors such as the vitamin D receptor or 
the thyroid hormone receptor (28, 47). Dimerization allows 
the retinoid receptors to bind to response elements on DNA to 
activate (or inactivate in some cases) gene transcription (28, 
47). Retinoic acid upregulates expression of its own 
receptors in promyelocytic cells (9). Therefore, increases in 
plasma concentrations of all-trans and 9-cls RA may upregulate 
expression of retinoid receptors (RAR and RXR), resulting in 
enhanced transcription of other RA responsive genes. Further 
studies are required to determine whether administration of 
13-cis-RA upregulates RAR or RXR expression in cattle, 
particularly in cells of the Immune system. 
Plasma concentrations of 13-cls-RA were elevated in 
treated animals in posttreatnent period II (13 - 18 d after 
105 
initiation of treatment, Figure lA). In animals treated with 
400 mg 13-cis-RA/d, concentrations of plasma 13-cis-RA 
appeared still to be elevated relative to baseline values at 
the beginning of the second experiment (data not shown). 
Therefore, the time between the second and third experiments 
was extended to 82 d compared to 43 d between the first and 
second experiments. Sustained elevation of 13-cis-RA in 
previously treated animals was unexpected because the half 
life of 13-cis-RA in rats was reported to be 58 ± 6 min. (19). 
Plasma concentrations of 13-cis-RA returned to negligible 
levels by 6 h after administration (19). The level of 
administration of 13-cis-RA to the rats was 2.5 mg/360 g of 
body weight (19) whereas dairy cattle on the highest treatment 
(400 mg/d) received a total of 3.2 mg/kg over a 7 d period. 
The slower elimination rate of cattle in the present 
study compared to rats may be because of differences in 
metabolism of 13-cis-RA. Alternatively, it may be a result of 
differences in route of administration. The 13-cis-RA was 
administered either intravenously or intraperitoneally to the 
rats (19) but was administered intramuscularly to the cattle. 
The intramuscular administration may slow release of 13-cis-RA 
to the blood stream, resulting in elevated plasma 
concentrations over extended time periods. 
Elevated plasma concentrations of RA isomers resulting 
from administration of 13-cis-RA may result in increased 
» 
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intestinal absorption of vitamin A. Expression of cellular 
retinol binding protein type-II (CRBP-II) in rats is 
upregulated by RA in the presence of RXR (31). Cellular 
retinol binding protein is involved in the intestinal 
absorption of vitamin A. Therefore, increased plasma 
concentrations of RA, specifically 9-cis RA, may influence 
intestinal absorption of vitamin A. Retinoic acid regulation 
of CRBP-II expression in cattle, however, has not been shown. 
Intracellular Concentrations of Ratinoio Acid Isomers 
Intracellular RA concentrations in isolated MNL were 
elevated in a dose-dependent manner (Table 1). Data presented 
are means from two sampling periods of two animals for each 
treatment during the third experiment. Intracellular 
concentrations of all-trans RA were elevated to a greater 
extent than 13-cis-RA concentrations in 13-cis-RA treated 
animals. These data suggest that 13-cis-RA is readily 
converted to all-trans RA inside cells but the conversion is 
slow enough to allow for elevation of the intracellular 13-
cis-RA concentration. This supports the suggestion that 13-
cis-RA provides a precursor pool for all-trans RA (14). The 
binding affinity of 13-cis-RA is less than 20% of the affinity 
of all-trans RA for human rRAR-a and -6 (12). 
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Plasma Concentrations of B-Carotene, Retinol, and a-Tocopherol 
Plasma concentrations of retinol and 6-carotene were not 
affected by administration of 13-cis-RA (Figure 2A and 2B). 
Plasma concentrations of B-carotene in Quebec herds averaged 
2880 ng/ml and ranged from 490 ng/ml to 11,210 ng/ml (4). 
Plasma concentrations of 3000 ng/ml are considered sufficient 
(4). In the present study, the B-carotene concentration in 
plasma averaged 8890 ng/ml which indicates the animals had 
more than adequate B-carotene status (Figure 2A). Cattle had 
access to lush pasture during much of the experimental periods 
which likely contributed to the high B-carotene concentrations 
in plasma. 
Plasma concentrations of retinol during the pretreatment 
period indicate the cattle had adequate vitamin A status prior 
to initiation of treatments (Figure 2B). Plasma 
concentrations of retinol averaged 360 ng/ml over the 
experimental periods. Plasma concentrations greater than 200 
ng/ml are indicative of adequate vitamin A status in cattle 
(34). Because hepatic concentrations of vitamin A were not 
determined, it is unknown whether intestinal absorption of 
vitamin A was altered in animals given 13-cis-RA. A sparing 
effect of 13-cis-RA on vitamin A is not evident, based on 
these data. Short- and long-term feeding of RA to rats 
decreased plasma retinol concentrations (25) whereas plasma 
retinol concentrations were not affected in humans by daily 
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administration of 1 mg of 13-cis-RA/kg of body weight for four 
months (41). Therefore, vitamin A metabolism may differ in 
rats and humans. Results of the present study indicating 1 3 -
cis-RA administration did not influence plasma retinol 
suggests that vitamin A metabolism in cattle may be more 
similar to vitamin A metabolism in humans than rats. 
In rats (3) and chickens (16), excess vitamin A (as 
retinyl palmitate) in the diet resulted in decreased 
concentrations of plasma a-tocopherol. In contrast, a high 
oral dose of vitamin A given to chickens in conjunction with 
intravenous administration of a-tocopherol had no effect on 
plasma concentrations of a-tocopherol (16). Results of these 
studies indicate that oral administration of vitamin A may 
impair absorption of a-tocopherol, resulting in lower plasma 
concentrations of a-tocopherol. Plasma concentrations of a-
tocopherol were not affected by 13-cis-RA administrations in 
the present study (Figure 3). Because 13-cis-RA was injected 
into muscle in the present study, increased plasma RA likely 
would not have had an effect on absorption of a-tocopherol in 
the cattle. 
Results of Blastogenasia Assays 
In vivo administration of 13-cis-RA had no effect on in 
vitro DNA-synthesis by resting or mitogen-stimulated MNL 
(Table 2). However, DNA synthesis was not as great in 
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cultures supplemented with 13-cis-RA in vitro as in cultures 
not supplemented with 13-cis-RA in vitro for both 
nonstimulated (P<,002) and mitogen-stimulated (P<.001) cells 
(Table 2). These data support a previous report indicating 
decreased proliferation as a result of 13-cis-RA 
s u p p l e m e n t a t i o n  o f  P W M - s t i m u l a t e d  c u l t u r e s  o f  b o v i n e  M N L  ( 3 5 ) .  
Tjoelker et al. (1988) reported that inhibition of in 
vitro DNA-synthesis by RA differed depending on lactational 
status and vitamin status (44). Addition of RA to MNL 
cultures inhibited DNA-synthesis by MNL from cattle 
supplemented with adequate vitamin A but did not inhibit DNA-
synthesis by MNL from cattle supplemented with adequate 
vitamin A and additional 6-carotene. They suggested that 
elevated plasma concentrations of 6-carotene may have 
prevented RA from inhibiting proliferation in vitro (44). 
Plasma concentrations of fi-carotene in cattle in the present 
study, however, were approximately 2-fold greater than in the 
study by Tjoelker et al. (45). Therefore, differences in 
results between studies likely are not attributable to fi-
carotene status. 
Although DNA synthesis was less in cultures supplemented 
with 13-cis-RA than unsupplemented cultures in the present 
study, it was not abrogated. Therefore, the lower DNA 
synthesis likely was not a result of toxicity of 13-cis-RA. 
The same concentration of 13-cls-RA was added to mitogen-
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stimulated cultures of bovine MNL by Tjoelker et al. (45) and 
did not inhibit DNA synthesis by MNL from cows supplemented 
with retinol and 6-carotene. 
Retinoic acid has induced differentiation of the myeloid 
leukemic cell line, HL-60, into granulocytic cells (11). This 
was mediated through the RAR-a receptor. Other research has 
reported that several human hematopoietic cell types 
constitutively express mRNA for RAR-a (27, 46). The amount of 
mRNA expressed for RAR-a was not related to proliferation 
(27). Also, RAR-a expression was not upregulated by RA in 
human cells (27). Although addition of 13-cis-RA to cultures 
previously was shown to inhibit proliferation in response to 
mitogenic stimulation, MNL function was enhanced as indicated 
by increased production of IgM (35). Therefore, lower DNA-
synthesis in vitro by mitogen stimulated MNL in the present 
study may be the result of enhanced differentiation rather 
than inhibited proliferation. 
» 
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CONCLUSIONS 
Intramuscular injections of 13-cis-RA dissolved in DMSO 
increased plasma concentrations of 13-cis, all-trans, and 9-
cis RA in a dose-dependent manner, but had no effect on plasma 
concentrations of retlnol, fi-carotene, or a-tocopherol. In 
plasma, concentrations of 13-cis-RA were elevated to a greater 
extent than all-trans RA. In contrast. Intracellular 
concentrations of all-trans RA were elevated to a greater 
extent than 13-cis-RA. This suggests that 13-cls-RA provides 
a precursor pool for all-trans RA which is the biologically 
active metabolite of vitamin A in many functions. 
In vivo administration of 13-cls-RA had no effect on in 
vitro DNA-synthesis by Con A- or PWM-stimulated MNL. However, 
levels of administration were low compared to levels tolerated 
by humans (1, 41). In vitro addition of RA to blastogenesis 
assays resulted in decreased DNA synthesis by MNL relative to 
cultures which did not receive additional RA. Further 
research with higher levels of RA administration may be 
required to see an effect on DNA-synthesis assays as a result 
of in vivo treatment. , 
Administration of 13-cls-RA was shown to be an effective 
method for altering plasma and intracellular concentrations of 
RA Isomers and may provide a valuable tool for manipulation 
and study of vitamin A stauts in cattle. 
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In vitro addition of RA to MNL cultures stimulated with 
mitogens alters proliferation responses. Further research 
using greater levels of 13-cis-RA administration may provide a 
better indication of effects of RA on immune function. 
Additionally, further research is required to determine 
whether, upon stimulation of MNL, RA may induce immune cells 
to differentiate into effector cells without undergoing 
extensive proliferation. 
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TABLE 1. Comparison of concentrations of retinoic acid (RA) isomers in mononuclear 
cells (MNL) and plasma. 
Days RA Isomer 13-Cis-RA administration fma/dl 
0 100 200 400 
Retinoic acid in MNL (na RA/lo' cells) 
Pretreatment All-trans 1.0 1.5 .8 1.7 
8 and 15 All-trans 2.0 2.8 6.9 10.1 
13-Cis .3 1.6 4.0 5.4 
22 and 24 All-trans 1.8 6.0 3.8 7.8 
13-Cis — 1.6 2.5 3.6 
35 and 37 All-trans 2.0 1.7 1.8 2.2 
13-Cis .8 .8 .7 1.8 
Retinoic acid in Dlasma fna RA/mll^ 
Mean All-trans 1.0 3.8 6.8 10.4 
13-Cis 1.0 7.8 14.3 21.7 
Data presented for intracellular concentrations of RA isomers are means of two 
animals for each treatment from the third replication only. 
Cells were obtained on the days indicated relative to initiation of treatments and 
combined to provide adequate volume for analysis. 
Values represent mean plasma concentrations for all time periods and all 
replications. 
TABLE 2. Effects of in vitro supplementation with 13-cis-retinoic acid on 
nonstimulated and mitogen-stimulated DNA-synthesis . 
13-Cis-retinoic acid administration fma/d in vivo)^ 
Stimulation -RA^ 
0 
+RA -RA 
100 
+RA -RA 
200 
+RA -RA 
400 
+RA 
Nonstimulated 4+ 2 5 3 8 5 17 8 
Con A (Mg/ml) 3.9 173^ 120 208 159 241 189 239 171 
00 
183 131 214 160 223 178 237 166 
15.6 124 97 111 90 122 100 135 95 
PWM (fig/ml) .08 159 108 172 118 216 173 218 145 
.40 172 121 188 139 235 189 232 160 
to
 
o
 
153 100 167 112 194 143 191 128 
^ Values represent mean counts per minute x 10 . 
^ There was no effect on DNA synthesis of in vivo administration of 13-cis-retinoic 
acid to cattle. 
^ Cultures were unsupplemented (-RA) or supplemented (+RA) with 13-cis-retinoic acid 
. (10*® M) . 
Supplementation with 13-cis-retinoic acid inhibited (P<.002) DNA-synthesis in 
nonstimulated cultures. 
® Supplementation with 13-cis-retinoic acid inhibited (P<.001) DNA-synthesis in 
mitogen-stimulated cultures. 
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Figure 1. Plasma retinoic acid (RA) concentrations in dairy 
cattle receiving 0, 100, 200, or 400 mg 13-cis-RA/d for seven 
d in three replicate experiments (n=6 for each treatment). 
Plasma concentrations of RA increased in a dose dependent 
manner for 13-cis-RA (P=.0001, A), all-trans RA (P-.0333, B) , 
and 9-cis RA (P=.0074, C). Animals were sampled during a 
pretreatment period (• , -5, -3, and 0 d), treatment period 
(B I 1-6 d), and posttreatment periods , 7-12 d and gg, 
13-18 d). 
Figure 2. Plasma retinol and fi-carotene concentrations in 
dairy cattle receiving 0, 100, 200, or 400 mg 13-cis-retinoic 
acid (RA)/d for seven d in three replicate experiments (n=6 
for each treatment). Animals were sampled during a 
pretreatment period ( • , -5, -3, and 0 d), treatment period 
(0 , 1-6 d), and posttreatment periods ( g , 7-12 d and g, 
13-18 d). Plasma concentrations of retinol and B-carotene 
were unaffected by 13-cis-RA administration. 
Figure 3. Plasma a-tocopherol concentrations in dairy cattle 
receiving 0, 100, 200, or 400 mg 13-cis-retinoic acid (RA)/d 
for seven d in three replicate experiments (n=6 for each 
treatment). Animals were sampled during a pretreatment period 
( g , -5, -3, and 0 d), treatment period ( Q, 1-6 d), and 
posttreatment periods ( ^  , 7-12 d and g, 13-18 d). Plasma 
concentrations of a-tocopherol were unaffected by 13-cis-RA 
administration. 
I 
117 
s 
3 
3 
m 
i 
< 
P6 
I 
^ Figure 1. 
I 
S 
g 
.52 
U 
25 
20 
15 
10 
5 
0 
0 100 200 400 
Treatment (13-Cis RA, mg/d) 
» 
118 
180001 
15000 
(u 12000 
1 
2 
S I 
CO. 
I 
Figure 2 
i 
0 
G 1 
1 
S 
600 
500 
400 
300 
200 
100 
0 
B 
I 
0 100 200 
Treatment (13-Cis-RA, mg/d) 
400 
t 
119 
Figure 3. 
7000 
^ 5000 
0 100 200 400 
Treatment (13-Cis-RA, mg/d) 
120 
REFERENCES 
1 Adelman, D.C., T.Y. Yen, W.G. Cumberland, N. Sidell, and A. 
Saxon. 1991. 13-Cis retinoic acid enhances in vivo 
B-lymphocyte differentiation in patients with variable 
immunodeficiency. J. Allergy Clin. Immunol. 88:705. 
2 Bardos, L., 0. Szenci, K. Oppel, K. Gerzi, and T. Varga. 
1991. Blood pH, plasma carotene, vitamin A, albumin and 
globulin concentrations in newborn calves and in dams 
during the first three days of the postnatal period. Acta 
Vet. Hung. 39:59. 
3 Blakely, S.R., G.V. Mitchell, M.Y. Jenkins, E. Grundel, and 
P. Whittaker. 1991. Canthaxanthin and excess vitamin A 
alter alpha-tocopherol, carotenoid and iron status in adult 
rats. J. Nutr. 121:1649. 
4 Block, E. and B. Farmer. 1987. The status of beta-carotene 
and vitamin A in Quebec dairy herds: factors affecting 
their status in cows and their effects on reproductive 
performance. Can. J. Anim. Sci. 67:775. 
5 Branstetter, R.F., R.E. Tucker, G.E. Mitchell,Jr., J.A. 
Boling, and N.W. Bradley. 1973. Vitamin A transfer from 
cows to calves. Internat. J. Vit. Nutr. Res. 43:142. 
6 Carman, J.A. and C.E. Hayes. 1991. Abnormal regulation of 
IFN-gamma secretion in vitamin A deficiency. J. Immunol. 
147(4):1247. 
I 
121 
7 Chew, B.P., L.L. Hollen, J.K. Millers, and M.L. Herlugson. 
1982. Relationship between vitamin A and beta-carotene in 
blood plasma and milk and mastitis in Holsteins. J. Dairy 
Soi. 65:2111. 
8 Chew, B.P. and L.A. Johnston. 1985. Effects of supplemental 
vitamin A and ^-carotene on mastitis in dairy cows. J. 
Dairy Sci. 68(Suppl. 1):191. (Abstr.) 
9 Chomienne, C., N. Balitrand, P. Ballerini, S. Castaigne, H. 
de The, and L. Degos. 1991. All-trans retinoic acid 
modulates the retinoic acid receptor-alpha in promyelocytic 
cells. J. Clin. Invest. 88:2160. 
10 Chun, T.Y., J.A. Carman, and C.E. Hayes. 1992. Retinoid 
repletion of vitamin A - deficient mice restores IgG 
responses. J. Nutr. 122:1062. 
11 Collins, S.J., K.A. Robertson, and L. Mueller. 1990. 
Retinoic acid-induced granulocytic differentiation of HL-60 
myeloid leukemia cells is mediated directly through the 
retinoic acid receptor (RAR-alpha). Mol. Cell. Biol. 
10:2154. 
12 Crettaz, M., A. Baron, 6. Siegenthaler, and W. Hunziker. 
1990. Ligand specificities of recombinant retinoic acid 
receptors RAR-alpha and RAR-beta. Biochem. J. 272:391. 
13 Dahlguist, S.P. and B.P. Chew. 1985. Effects of vitamin A 
and /9-carotene on mastitis in dairy cows during the early 
dry period. J. Dairy Sci. 68(Suppl. 1):191. (Abstr.) 
i 
122 
14 Fiorella, P.O. and J.L. Napoll. 1991. Expression of 
cellular retinoic acid binding protein (CRABP) in 
Escherichia coll. Characterization and evidence that 
holo-CRABP is a substrate in retinoic acid metabolism, J. 
Biol. Chem. 266:16572. 
15 Franklin, S.T., J.W. Young, and B.J. Nonnecke. 1991. 
Effects of ketones, acetate, butyrate, and glucose on 
bovine lymphocyte proliferation. J. Dairy Sci. 74:2507. 
16 Frigg, M. and J. Broz. 1984. Relationships between vitamin 
A and vitamin E in the chick. Int. J. Vltam. Nutr. Res. 
54:125. 
17 Giguere, V., E.S. Ong, P. Segui, and R.M. Evans. 1987. 
Identification of a receptor for the morphogen retinoic 
acid. Nature 330:624. 
18 Goff, J.P. and J.R. Stabel. 1990. Decreased plasma retinol, 
alpha-tocopherol, and zinc concentration during the 
periparturlent period: Effect of milk fever. J. Dairy Sci. 
73:3195. 
19 Guchelaar, H.J., S. Wouda, G.J.J. Beukeveld, N.H. Mulder, 
and J.W. Oosterhuls. 1992. Pharmacokinetics of parenteral 
13-cls-retinoic acid formulations in rats. J. Pharm. Sci. 
81(5):432. 
20 Heyman, R.A., D.J. Mangelsdorf, J.A. Dyck, R.B. Stein, G. 
Eichele, R.M. Evans, and C. Thaller. 1992. 9-Cis retinoic 
123 
acid is a high affinity ligand for the retinoid X receptor. 
Cell 68:397. 
21 Johnston, L.A. and B.P. Chew. 1984. Peripartum changes of 
plasma and milk vitamin A and beta-carotene among dairy 
cows with or without mastitis. J. Dairy Sci. 67:1832. 
22 Kaplan, L.A., J.A. Miller, and E.A. Stein. 1987. 
Simultaneous measurement of serum retinol, tocopherols, 
carotenes, and carotenoids by high performance liquid 
chromatography. J. Clin. Lab. Anal. 1:147. 
23 Kehrli, M.E.,Jr., B.J. Nonnecke, and J.A. Roth. 1989. 
Alterations in bovine lymphocyte function during the 
periparturient period. Am. J. Vet. Res. 50:215. 
24 Kehrli, M.E.,Jr., B.J. Nonnecke, and J.A. Roth. 1989. 
Alterations in bovine neutrophil function during the 
periparturient period. Am. J. Vet. Res. 50:207. 
25 Keilson, B., B.A. Underwood, and J.D. Loerch. 1979. Effects 
of retinoic acid on the mobilization of vitamin A from the 
liver in rats. J. Nutr. 109:787. 
26 Kendall, K.A. and K.E. Harshbarger. 1953. Plasma carotene 
and vitamin A levels of dairy cows before and after 
parturition. J. Dairy Sci. 36:583. 
27 Kizaki, M., H.P. Koeffler, C. Lin, and C.W. Miller. 1990. 
Expression of retinoic acid receptor mRNA in hematopoietic 
cells. Leukemia Res. 14(7):645. 
124 
28 Lee, M.S., S.A. Kllewer, J. Provencal, P.E. Wright, and 
R.M. Evans. 1993. Structure of the retinoid X receptor a 
DNA binding domain: a helix required for homodimeric DNA 
binding. Science 260:1117. 
29 Levin, A.A., L.J. Sturzenbecker, S. Kazmer, T. Bosakowski, 
C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. 
Rosenberger, A. Lovey, and J.F. Grippo. 1992. 9-Cis 
retinoic acid stereoisomner binds and activates the nuclear 
receptor RXR-alpha. Nature 355:359. 
30 Madani, K.A. 1986. Retinoic acid: a general overview. Nutr. 
Res. 6:107. 
31 Mangelsdorf, D.J., K. Umesono, S.A. Kliewer, U. Borgmeyer, 
E.S. Ong, and R.M. Evans. 1991. A direct repeat in the 
cellular retinol-binding protein type II gene confers 
differential regulation by RXR and RAR. Cell 66:555. 
32 Nagahata, H., N. Kojima, I. Higashitani, H. Ogawa, and H. 
Noda. 1991. Postnatal changes in lymphocyte function of 
dairy calves. J. Vet. Med. 38:49. 
33 Napoli, J.L. 1986. Quantification of physiological levels 
of retinoic acid. Page 112 in Methods in Enzymology, volume 
123, vitamins and coenzymes, part H. Academic Press, Inc., 
Orlando, FL. 
34 National Research Council. 1988. Nutrient requirements of 
dairy cattle. 6th rev. ed. Update. Natl. Acad. Sci., 
Washington, DC. 
125 
35 Nonnecke, B.J., S.T. Franklin, R.L. Horst, and T.A. 
Reinhardt. 1993. In vitro modulation of function, 
proliferation, and phenotype of bovine mononuclear 
leukocytes by 13-cis retinoic acid. J. Nutr. Immunol, (in 
press) 
36 Nonnecke, B.J., T.A. Reinhardt, and S.T. Franklin. 1993. 
Retinoid-induced modulation of immunoglobulin M secretion 
by bovine mononuclear leukocytes in vitro. J. Dairy Sci. 
76:2175. 
37 Oldham, E.R., R.J. Eberhart, and L.D. Muller. 1991. Effects 
of supplemental vitamin A or beta-carotene during the dry 
period and early lactation on udder health. J. Dairy Sci. 
74:3775. 
38 Oliver, S.P. and B.A. Mitchell. 1983. Susceptibility of 
bovine mammary gland to infections during the dry period. 
J. Dairy Sci. 66:1162. 
39 Petkovich, M., N.J. Brand, A. Krust, and P. Chambon. 1987. 
A human retinoic acid receptor which belongs to the family 
of nuclear receptors. Nature 330:444. 
40 Ross, A.C. 1992. Vitamin A status: Relationship to immunity 
and the antibody response. Proc. Soc. Exp. Biol. Med. 
200:303. 
41 Sidell, N., M.J. Connor, B. Chang, N.J. Lowe, and H. Borok. 
1990. Effects of 13-cis retinoic acid therapy on human 
126 
antibody responses to defined protein antigens. J. Invest. 
Dermatol. 95:597. 
42 Sidell, N., E. Famatiga, and S.H. Golub. 1984. 
Immunological aspects of retinoids in humans. II. Retinoic 
acid enhances induction of hemolytic plaque-forming cells. 
Cellular Imm. 88:374. 
43 Smith, K.L., D.A. Todhunter, and P.S. Schoenberger. 1985. 
Environmental pathogens and intramammary infection during 
the dry period. J. Dairy Sci. 68:402. 
44 Tjoelker, L.W., B.P. Chew, T.S. Tanaka, and L.R. Daniel. 
1988. Bovine vitamin A and beta-carotene intake and 
lactational status. 2. Responsiveness of mitogen-stimulated 
peripheral blood lymphocytes to vitamin A and beta-carotene 
challenge in vitro. J. Dairy Sci. 71:3120. 
45 Tjoelker, L.W., B.P. Chew, T.S. Tanaka, and L.R. Daniel. 
1988. Bovine vitamin A and beta-carotene intake and 
lactational status. 1. Responsiveness of peripheral blood 
polymorphonuclear leukocytes to vitamin A and beta-carotene 
challenge in vitro. J. Dairy Sci. 71:3112. 
46 Unknown, 1990. Expression of a retinoic acid -receptor 
gene is regulated by retinoic acid itself. Nutr. Rev. 
48(9):355. 
47 Yu, V.C., C. Delsert, B. Andersen, J.M. Holloway, o.v. 
Devary, A.M. Naar, S.Y. Kin, J.M. Boutin, C.K. Glass, and 
M.G. Rosenfeld. 1991. RXR-beta: A coregulator that enhances 
127 
binding of retinoic acid, thyroid hormone, and vitamin D 
receptors to their cognate response elements. Cell 67:1251. 
Zelent, A., A. Krust, M. Petkovich, P. Kastner, and P. 
Chambon. 1989. Cloning of murine alpha and beta retinoic 
acid receptors and a novel receptor gamma predominantly 
expressed in skin. Nature 339:714. 
128 
PAPER III. MODULATION OF MONONUCLEAR LEUKOCYTE FUNCTION IN 
DAIRY CATTLE BY ADMINISTRATION OF 13-CIS-RETINOIC 
ACID 
» 
129 
Modulation of Mononuclear Leukocyte Function in Dairy Cattle by 
Administration of 13-Cis-Retinoio Jkoid 
8. T. FRANKLIN and J. W. YOUNG 
Nutritional Physiology Group 
Department of Animal Science 
Iowa State University 
Ames 50011 
B. J. NONNECKE 
Agricultural Research Service, USDA 
National Animal Disease Center 
Ames, lA 50010 
130 
ABSTRACT 
Eight Holstein heifers were randomly assigned to 
treatments In three replicate experiments to evaluate effects 
of administration of 13-cis-retinoic acid on immune function. 
Treatments were 0 (vehicle only), 100, 200, or 400 mg 13-cis-
retinolc acld/d for seven d. Vehicle was dimethyl sulfoxide. 
Samples were obtained for three d prior to initiation of 
treatments and periodically during the 18 d period after 
initiation of treatments. In vitro IgM production, serum IgM 
and IgG content, phenotype of circulating mononuclear 
leukocytes, and total blood leukocyte counts were monitored. 
In vivo administration of 13-cis-retinoic acid did not affect 
in vitro IgM production in nonstlmulated and pokeweed mltogen-
stimulated cultures. However, supplementation of mononuclear 
cultures in vitro with 13-cis-retinoic acid enhanced IgM 
production. Serum IgG concentration in cattle receiving 400 
mg 13-cis-retinoic acid/d was Increased during the 13 to 18 d 
period after Initiation of treatments. Additionally, the 
percentage of circulating B-cells in cattle receiving 200 mg 
13-cls-retinolc acid was elevated compared to pretreatment 
values. Total number of peripheral blood leukocytes were not 
affected by treatment. These results suggest 13-cis-retinoic 
acid modulates bovine mononuclear function resulting in 
altered B-cell numbers and function. 
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Key words: Retinoio acid, bovine lymphocyte function, 
immunoglobulin, vitamin A. 
Abbreviations Used in This Paper: 
DM80 = Dimethyl sulfoxide 
FBS = Fetal bovine serum 
HBSS = Hank's balanced salt solution 
MNL = Mononuclear leukocytes 
NADC = National Animal Disease Center 
PWM = Pokeweed mitogen 
RA = Retlnolc acid 
RAR = Retlnolc acid receptor 
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INTRODUCTION 
Vitamin A, a fat soluble vitamin, is required for growth, 
maintenance of healthy epithelium, bone formation, and 
reproduction. It also is involved in immune function in many 
species (23) . Vitamin A deficiency has resulted in decreased 
antibody production and depressed natural killer cell 
activity, resulting in increased susceptibility to infectious 
diseases (23). Effects of vitamin A supplementation on immune 
function include increased cellular responses and antibody 
production responses (23). 
Dairy cows experience during the periparturient period, a 
decline in plasma vitamin A concentrations that may allow them 
to be classified as marginally deficient in vitamin A (<200 
ng/ml) (8, 13). Dairy cows also are naturally 
immunocompromised during the periparturient period (11, 12) 
and incidence of new intramammary infection is high (20, 25). 
The decrease in immune function and increase in susceptibility 
to new intramammary infection in dairy cows during the 
periparturient period may be related to the decrease in plasma 
concentrations of vitamin A. Cows with lower plasma vitamin A 
had higher milk somatic cell counts than cows with higher 
plasma vitamin A (2). Cows with mastitis had lower plasma 
vitamin A than cows without mastitis (10). Administration of 
G-carotene and vitamin A in the form of retinyl esters reduced 
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milk somatic cell count during early lactation (3) and 
incidence of new infections during the early dry period (5). 
In contrast, Oldham et al., (19) found no effect of 
supplementation of fl-carotene and retinyl esters on new 
intramammary infections in cows during the early dry period or 
periparturient period (19). 
Retinoic acid (RA) is an active metabolite of vitamin A 
that has been shown to modulate immune function in several 
species (1, 4, 21). Hematopoietic cell types of different 
lineages express mRNA for retinoic acid receptor-a (RAR-a) 
(15). Therefore, vitamin A likely functions through RA to 
mediate function of many types of immune cells. In cattle, RA 
has been reported to modulate function of bovine immune cells 
by altering in vitro proliferation and Ig production (14, 16, 
18, 26) and in vitro phagocytosis by bovine neutrophils (27). 
The purpose of the present study was to evaluate effects of 
administration of vitamin A to dairy cattle on general 
parameters of immune function such as in vitro IgM production 
in response to mitogen, circulating concentrations of IgM and 
IgG, total blood luekocyte numbers, and phenotype of 
circulating leukocytes. 13-Cis-RA, a metabolite of vitamin A, 
was utilized because it is less toxic than all-trans-RA, has a 
longer half-life, and is readily converted to all-trans-RA. 
Therefore, 13-cis-RA provides a precursor pool for conversion 
to all-trans-RA (6). 
I 
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MATERIALS AND METHODS 
Animals and Treatments 
Experimental procedure is described by Franklin et al. 
(7). Briefly, eight Holstein heifers were randomly assigned 
to treatments over three replicate experiments. Treatments 
were 0, 100, 200, or 400 mg 13-cis-RA (Sigma Chemical Co., St. 
Louis, MO) daily for seven d. 
Serum and whole blood samples were obtained by jugular 
venipuncture. Whole blood samples for total leukocyte counts, 
and serum samples for Ig determinations were obtained on -5 
and -3 d, then daily from 0 to 18 d. Whole blood samples for 
isolation of leukocytes used in IgM production assays and flow 
cytometry analysis were obtained on -5, -3, 0 to 4, 7 to 11, 
14, 16, and 18 d. 
Whole blood was collected into vacutainer tubes and 
immediately placed in the dark. Tubes were centrifuged (20 
min, 1171 X g, 21* C), serum was harvested and samples were 
stored in -20' C freezers. 
Leukocyte numbers in whole blood from heparinized 
vacutainer tubes or containing 10% ACD were determined 
electronically. 
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Isolation of Mononuclear Leukocytes for igN-Produotion 
Cultures 
Mononuclear leukocytes (MNL) for IgM-production cultures 
were isolated as described by Franklin et al. (7). Cells were 
resuspended to a final concentration of 3.0 x 10^ cells/ml in 
RPMI-1640 medium. Enriched cells were typically greater than 
95% MNL and cell viability was greater than 95%. 
Mononuclear leukocytes for flow cytometric analysis were 
isolated by a different method. Five ml of whole blood 
containing, 10% acid citrate dextrose as an anticoagulant, was 
added to 10 ml Hank's balanced salt solution (HBSS, .015 mM 
without Ca^* and Mg^*, pH 7.2) in 50 ml conical tubes and 
subsequently subjected to hypotonic lysis to remove 
erythrocytes. Samples were centrifuged (10 min, 650 x g, 4' 
C) and supernatants were removed. Cells were washed in HBSS 
(10 min, 650 X g, 4" C), resuspended in HBSS containing .1% 
NaN3 and 1% FBS (first wash buffer) and transferred to 12 ml 
conical tubes. Samples were centrifuged (25 min, 250 x g, 4° 
C), resuspended in first wash buffer and counted (Celltrak-3B 
automated cell counter. Angel Engineering Corp., Trumbull, 
CT). Cell concentrations were adjusted to 4.0 x 10^ cells/ml 
and kept on ice. 
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igM-Produotion Cultures 
Cultures of MNL were established for in vitro IgM 
production using a previously described procedure with 
modifications (17). Briefly, 500 fil of pokeweed mitogen (PWM, 
.24 nq/ml) in RPMI-1640 were added to wells of 24 well tissue 
culture plates to provide a final concentration of .08 jig 
PWM/ml of culture. Unstimulated cultures received an 
equivalent volume of RPMI-1640. Five hundred /ul of fetal 
bovine serum (PBS, Hyclone Laboratories, Inc., Logan, UT) in 
RPMI-1640 were added to each well to provide 6.7% FES in 
culture. Cells (500 fil) were added to cultures to provide a 
final concentration of 1 x 10^ cells/ml. Cultures received an 
additional 25 fil of serum containing 13-cis-RA to provide a 
concentration of lO'® M 13-cis-RA in culture or 25 ul serum as 
controls. Stock 13-cis-RA was initialized solubilized in 100% 
HPLC ethanol. Cultures were incubated for 14 d at 39° C in 
humidified chambers containing 5% COg. Supernatants were 
harvested and diluted 1:250 in carbonate buffer (.05 M, pH 
9.6) for quantitation of polyclonal IgM concentrations. 
Remaining supernatants were stored in -20* C freezers. 
Quantitation of Ig in Serum and Culture Supernatants 
Procedures used for quantitation of IgM in culture 
supernatants were described previously (17). Samples for all 
animals for one day were analyzed together. The procedure was 
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modified to analyze serum samples for IgG and IgM 
concentrations. Serum samples for IgM and IgG quantitation 
were diluted in carbonate buffer 1:100,000 and 1:400,000, 
respectively. Standards for IgM (5, 10, 20, and 40 ng/ml, ICN 
Biochemicals, Costa Mesa, CA) and IgG (10, 20, 40, and 80 
ng/ml, ICN Biochemicals) were prepared in carbonate buffer. 
The initial incubation period for IgG analysis at 39' C for 1 
h under agitation, whereas the initial incubation for IgM 
analysis was overnight at 4* C in a humidified atmosphere. 
Samples were analyzed for concentrations of Ig in ng/ml and 
data were converted to percent relative to controls. 
Plow Cytometry 
Peripheral blood MNL were labeled with monoclonal 
antibodies (MAb) to bovine leukocyte surface antigens (Table 
1) . Approximately 2 x 10® cells in 50 ul of first wash buffer 
were added to duplicate wells of 96-well round bottom 
microtiter plates. Monoclonal antibodies were diluted 1:150 
in first wash buffer. Fifty ul of MAb were added to 
appropriate wells and plates were placed on ice for 30 min. 
Plates were then washed (2 min, 800 x g, 4* C) twice with 
first wash buffer and cell pellets were resuspended to 
approximately 50 fil in first wash buffer. Fifty ul secondary 
antibodies (1:500 dilution of FITC-conjugated goat F(ab')2 
fragment in first wash buffer) were added to wells and plates 
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were incubated in the dark, on ice for 15 min. Plates were 
washed (2 min, 800 x g, 4° C) three times using second wash 
buffer (HBSS containing .1% NaN3). Cell pellets were 
resuspended in approximately 100 Ml of second wash buffer. 
Flow cytometric analysis was performed using a Becton 
Dickinson FACScan (Becton Dickinson Immunocytometry Systems, 
San Jose, CA). Duplicate wells were combined and 
approximately 5000 cells exhibiting light scattering 
properties consistent with bovine MNL were analyzed. An argon 
laser with an excitation wavelength of 488 nm was used to 
detect cells labeled with secondary antibody. Emission 
fluorescence was detected with a 530 nm bandpass filter and 
converted to log fluorescence. Markers for negative control 
samples were positioned to provide approximately 2.5% 
background fluorescence and maintained for all samples. Data 
are expressed as percent of total cells expressing secific 
markers. 
Statistical Analyais 
An ANOVA was performed on data from in vitro IgM 
production assays, serum Ig concentrations, and flow 
cytometric analysis of circulating MNL. Where differences in 
treatment means were detected, means were further analyzed by 
the method of least significance difference. Treatment means 
for total blood leukocyte counts were analyzed by studen't t 
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test. Data from serum analyses of Ig and total leukocyte 
counts were divided into pretreatment (-5, -3, and 0 d), 
treatment (1 through 6 d), posttreatment I (7 through 12 d), 
and posttreatment II (13 through 18 d). There were fewer 
sampling points for in vitro IgM production and flow 
cytometric analysis of circulating MNL. Therefore, data were 
divided into pretreatment (-5, -3, and 0 d), treatment (1 
through 4 and 7 d), and posttreatment (8 through 11, 14, 16, 
and 18 d). 
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RESULTS AMD DISCUSSION 
Administration of 13-cis-RA to dairy cattle elevated 
plasma concentrations of 13-cis-, all-trans-, and 9-cis-RA in 
a dose dependent manner (7). Concentrations of 13-cis-RA were 
elevated (P=.0001) to the greatest extent but concentrations 
of all-trans- and 9-cis-RA also were elevated significantly 
(P=.0333 and P=.0074, respectively). Throughout the 
experimental period, health of the animals was normal without 
clinical symptoms of vitamin A toxicity. This indicates that 
13-cis-RA administrations can alter normal plasma 
concentrations of RA isomers without apparent toxic effects 
and that 13-cis-RA is readily converted to all-trans-RA in 
cattle. 
In Vitro IgM Production 
Effects of 13-cis-RA administration on immune function of 
dairy cattle were evaluated. In vivo administration did not 
affect in vitro IgM production by PWM-stimulated HNL (Figure 
1). However, in vitro addition of 13-cis-RA (10"® M) to PWM-
stimulated cultures of MNL enhanced (P=.06) IgM production 
averaged over all treatments relative to cultures that did not 
receive additional 13-cis-RA (Figure 1). There was no 
interaction between in vivo administration of 13-cis-RA and in 
vitro supplementation of cultures with 13-cis-RA. These 
r 
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results confirm those of a previous report indicating 
increased production of polyclonal IgM in PWM-stimulated 
cultures of bovine MNL supplemented with 13-cis-RA at lo'® M 
(16). Additionally, in vitro supplementation with all-trans 
RA (.01 nM to 1.0 nM) of MNL cultures from vitamin A-
sufficient mice resulted in enhanced production of antigen-
specific IgG antibody compared to parrallel cultures not 
supplemented with RA (4). Therefore, results of the present 
study and previous studies indicate in vitro supplementation 
with RA isomers of MNL from animals of normal vitamin A status 
augments B-cell function. 
Serum immunoglobulin Conoentratlona 
Mean serum concentrations of IgM and IgG are presented as 
percent of pretreatment period values (Figure 2). Serum IgM 
concentrations were not affected by 13-cis-RA treatments 
during any time period (Figure 2A). There was a trend, 
however, toward increased serum IgM in cattle treated with 4 0 0  
mg 13-cis RA/d during the posttreatment II period. Total 
serum IgG concentrations were elevated (P<.05) in cattle 
treated with 400 mg 13-cis-RA/d relative to control animals 
during this time period (Figure 2B). Human subjects, of 
normal vitamin A status, treated daily with 1 mg of 13-cis-
RA/kg of body weight for 4 months had elevated concentrations 
of antigen specific IgG antibody in serum (24). 
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Increased concentrations of serum IgG in 13-cis-RA 
treated animals suggests 13-cis-RA can modulate bovine B-cell 
function in vivo. In contrast, in vitro production of IgM was 
not affected by in vivo administration of 13-cis-RA but was 
increased by in vitro supplementation with 13-cis-RA. These 
combined data suggest that RA must be available to the cell at 
the time of initiation of Ig production to be effective in 
increasing in vitro or in vivo Ig secretion. Mononuclear 
cells isolated from whole blood were, in effect, removed from 
the elevated concentrations of RA in the blood and no effect 
of in vivo 13-cis-RA administration on in vitro IgM production 
by PWM-stimulated MNL was observed. 
If the immediate presence of elevated concentrations of 
RA isomers is a requirement for enhanced B-cell function, 
administration of 13-cis-RA might be targeted to times of 
unusual stress in cattle (i.e. calving, shipping, weaning, or 
drying-off) as an aid in prevention of disease. 
Epidemiological studies indicate that administration of large 
doses of vitamin A (400,000 lU retinyl palmitate) to children 
with measles decreases morbidity and mortality (9). 
Beneficial effects also may be derived by administration of 
vitamin A to cattle with mastitis or other diseases as well as 
calves with respiratory infections or scours. 
Effects of 13-cis-RA administration to dairy cattle on 
serum IgG concentrations in the present study were not as 
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dramatic as those obtained in humans treated daily with 1 mg 
13-cis-RA/kg (24). Several factors may be responsible for the 
difference in response. Firstly, the lower response in cattle 
may be a result of species differences. Secondly, the amount 
of 13-cis-RA administered to human subjects (1 mg/per kg of 
bodyweight) was greater than the highest level administered to 
cattle (.4 mg/kg of bodyweight) in the present study. 
Thirdly, human subjects were immunized with a suboptimal 
dose of a specific antigen (KLH) and Ig responses to that 
antigen were determined (24). A suboptimal immunization dose 
was used to detect immunoenhancing effects of 13-cis-RA. A 
greater number (10 of 13) of humans treated with 13-cis-RA 
produced antigen-specific antibody compared to those (4 of 13) 
not treated with 13-cis-RA (24). In contrast, cattle in the 
present study were not challenged with antigen and in vitro 
production of IgM was in response to a polyclonal stimulator. 
Administration of 13-cis RA to cattle did enhance in vivo IgG 
production, however, enhancement of responses to a specific 
antigen by 13-cis-RA administration might be stronger. 
Evaluation of antigen responsiveness may be a more sensitive 
means of determining effects of vitamin A on immune function 
than evaluation of alterations in concentrations of polyclonal 
Ig. 
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Analysis of Circulating Mononuclear Leukocytes 
Alterations in total blood leukocyte numbers as a result 
of 13-cis-RA administration to cattle were not observed (Table 
2). A determination of the percentage of granulocytes 
compared to the percentage of MNL was not done and may provide 
useful information in future experiments. 
The phenotype of circulating MNL from control and 13-cis-
RA treated animals was analyzed by flow cytometry to evaluate 
effects of administration of 13-cis-RA on cell phenotype. 
There was an effect (P<.09) of treatment during the 
posttreatment period on the percentage of circulating B-cells 
(Table 3). The percentage of circulating B-cells was greater 
in animals receiving 200 mg 13-cis-RA/d compared to control 
animals or animals receiving 100 or 400 mg 13-cis-RA/d (Table 
3). A MAb specific for bovine plasma cells was not available 
at the time of the experiment. Therefore, it was not possible 
to determine by flow cytometric examination whether RA alters 
B-cell differentiation of bovine B-cells and drives B-cells 
toward terminal differentiation into plasma cells or whether 
an earlier stage of B-cells is induced to secrete more 
antibody. Development of a MAb specific for bovine plasma 
cells would provide additional information on the extent of B-
cell differentiation in response to RA. This would provide an 
indication of the effects of RA in vivo on B-cells. 
There were significant differences in percentages of 
I 
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circulating CD8* cells during the treatment and posttreatment 
periods (Table 3). Because these differences were present 
prior to initiation of treatments, it is unlikely differences 
in CDS* T-cells were a result of 13-cis-RA treatment effects. 
No other cell type was altered as a result of administration 
of 13-cis-RA. 
The mechanism by which RA augments Ig production has been 
shown to be indirectly through the T-helper cell population 
whereas retinol acts directly on B-cells (28). Preincubation 
of isolated human cord blood T-cells with RA, but not retinol, 
enhanced Ig production when the T-cells were added to B-cell 
and monocyte cultures (28). Daily administration of 1 mg 13-
cis-RA/kg of body weight to humans increased the percentage of 
circulating CD4* T-cells from approximately 30% to 
approximately 45% after 2 months of administration (22). The 
percentage of circulating B-cells was not determined. Similar 
results were obtained in mice (4). Vitamin A-deficient mice 
had fewer T-helper cells compared to vitamin A-sufficient 
mice. In vitro supplementation with RA of MNL cultures from 
vitamin A-deficient mice restored the T-helper cell frequency 
(4). In contrast, in vitro supplementation of PWM-stimulated 
bovine MNL cultures with 13-cis-RA decreased but did not 
abbrogate proliferation of CD4* T-helper cells relative to 
parrallel unsupplemented cultures (16). 
Reasons for these differences in responsiveness to RA are 
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not apparent. Percentage of circulating T-helper cells in 
humans increased after two months of treatment with 13-cis-RA 
at higher doses than those administered to cattle in the 
present study (22). Similarly, a decrease in the percentage 
of T-helper cells in mice was observed after the mice had 
become vitamin A-deficient (4). Thus, extremes in either 
supplementation or deficiency of vitamin A may be a 
prerequisite in cattle to affect T-helper cell populations. 
Studies using larger doses of 13-cis-RA for longer time 
periods may be necessary to determine whether circulating CD4+ 
T-cells are affected by alterations in vitamin A status in 
dairy cattle. 
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CONCLUSIONS 
Administration of 400 mg 13-cis-RA/d to dairy cattle 
enhanced serum IgG concentrations. There was a tendency for an 
increase in percentage of circulating B-cells in animals 
receiving 200 mg 13-cis-RA/d. Additionally, in vitro 
supplementation of PWM-stimulated cultures of bovine MNL 
resulted in greater IgM production relative to unsupplemented 
cultures regardless of in vivo treatment. Previous in vitro 
studies found enhanced IgM production (18) and decreased 
proliferation of CD4+ T-cells (16) in PWM-stimulated cultures of 
bovine MNL supplemented with 13-cis-RA. Taken together these 
data indicate that 13-cis-RA modulates humoral immune function 
of dairy cattle, probably through indirect effects on the T-
helper cell population. Research is needed to determine effects 
of retinoic acid isomers on the profile of cytokines secreted by 
MNL and their subsequent effects on B-cell differentiation in 
cattle with varying levels of vitamin A status. 
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TABLE 1. Monoclonal antibodies used in flow cytometric 
analysis of leukocyte antigen expression. 
Specificity MAb designation Ig isotype 
CD2 (Pan T) BAQ95A IgGi 
CDS (TgytQjoxic/suppressor) CACT80C IgG^ 
CD4 (Theiper/ipducgp) GC501A IgM 
B-cell (32) BAQ44A IgM 
Macrophage (M2) CH137A IgM 
Null cells (N2) BAQ4A IgGi 
Interleukin-2 receptor (ACTS) CACT116A IgG, 
MHC Class II TH14B IgGj 
^ Monoclonal antibodies from VMRD, Inc., Pullman, WA. 
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TABLE 2. Total numbers of blood leukocytes from control cattle 
and cattle treated with 13-cis-retinoic acid . 
13-Cis-retinoic acid administration (ma/d) 
Time period^ Q Ififi 400 
Pretreatment 6.8±.l 7.0 ± .4 7.4 ± .2 6.5±.2 
Treatment 6.7±.3 7.1 ± .3 7.3 ± .1 6.6±.3 
Posttreatment I 6.7 ± .2 6.8 ± .3 7.6 ± .2 6.5±.3 
Posttreatment II 6.8 ± .2 7.0 ± .3 7.6 ± .2 6.1 ± .1 
Values represent cell number (x 10 ) +/- SEM. 
Time periods were pretreatment (-5, -3, and 0 d), treatment 
(1-6 d), posttreatment I (7-12 d), and posttreatment II (13-
18 d). 
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TABLE 3. Percentages of circulating blood leukocytes 
expressing cell markers from control cattle and cattle treated 
with 13-cis-retinoic acid . 
13-Cis-retinolc acid administration fma/d) 
Marker Time oeriod^ 0 100 200 400 
CD2 TPl 38 36 36 34 
TP2 41 37 38 37 
TP3 40 35 35 37 
CD4 TPl 14 16 16 17 
TP2 14 15 15 16 
TP3 14 15 14 16 
CD8 TPl! 20 17 15 13 
TP2: . 20 17 16 12 
TP3 20 15 15 11 
B-cells TPl 32 33 37 34 
TP2 27 28 34 27 
TP3 29 28 40 31 
Null cells TPl 11 10 9 9 
TP2 10 10 9 9 
TP3 10 9 9 8 
IL-2R TPl 38 35 36 32 
TP2 36 35 35 32 
TP3 39 36 35 34 
Class II TPl 75 74 68 78 
TP2 75 72 69 75 
TP3 72 69 68 74 
Monocyte TPl 4 3 2 3 
TP2 3 2 2 2 
TP3 3 2 2 2 
Values represent mean percent of total cell number 
expressing specific markers. 
Time periods were TPl (pretreatment; -5, -3, and 0 d), TP2 
(treatment; 1-4, and 7 d), ahd TP3 (7 - 11, 14, 16, and 18 
d), and posttreatment II (13 - 18 d). 
Indicates an effect of 13-cis retlnolc acid administration 
in vivo (P < .09). 
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14 1 
12 -
Treatment (13-cis RA, mg/d) 
Figure 1. IgM concentrations in pokeweed mitogen stimulated 
cultures of bovine mononuclear leukocytes from animals treated 
with 0, 100, 200, or 400 mg 13-cis-RA daily for seven days. 
Solid bars represent cultures not supplemented with 13-cis-RA 
(lo' M) in vitro and hashed bars represent cultures 
supplemented with 13-cis-RA (10 M) in vitro. Concentration 
of IgM in control (nonstimulated) cultures averaged 1.6 ± .02 
ng/ml and was not affected by in vivo administration of 13-
cis-RA to cattle or in vitro supplementation of cultures with 
13-cis-RA. Concentration of IgM in pokeweed mitogen-
stimulated cultures was not affected by in vivo administration 
of 13-cis-RA to cattle but supplementation of cultures in 
vitro with 13-cis-RA (10' M) enhanced IgM production (P<.06, 
n=6) . 
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GENERAL SUMMARY 
Plant lectins are polyclonal stimulators of mononuclear 
leukocytes (MNL) in in vitro systems. Pokeweed mitogen (PWM) 
is a plant lectin that stimulates increased production of igM 
in vitro by B-cells of many species, including cattle. It is 
considered a T-dependent, B-cell mitogen in murine and human 
systems. Depletion of CD4+ T-helper cells from bovine MNL 
cultures is known to decrease proliferative responses of MNL 
to PWM stimulation. In bovine MNL cultures, the specific-cell 
types affected, however are unknown. For this reason, 
longitudinal changes in proliferation and cell phenotype in 
bovine MNL cultures stimulated by PWM were investigated 
(Section I). Cell numbers in both PWM-stimulated and 
nonstimulated cultures declined by 48 h to less than 45% of 
the number originally seeded, an effect likely induced by 
stress of adaption to culture. Thereafter, cell numbers 
increased through 8 d in PWM-stimulated cultures to greater 
than 100% if the number originally seeded and remained 
constant through 14 d, whereas cell numbers in nonstimulated 
cultures continued to decline. 
Flow cytometric analysis of cells at 48 h intervals 
revealed proliferation occurred primarily in the CD4+ T-helper 
cell population. These results indicate that PWM induces 
proliferation of T-helper cells and suggests enhanced IgM 
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secretion by B-cells in vitro is mediated by expansion of the 
CD4+ T-helper cell population. This is substantiated by the 
results indicating increased expression of activation 
antigens, the IL-2 receptor and the MHC class II antigen, by 
PWM-stimulated MNL. The observation that enhanced IgM 
secretion by B-cells in vitro may be mediated by expansion of 
the CD4+ T-helper cell population is key to understanding 
results obtained in Section III. 
Vitamin A, a fat soluble vitamin, is essential for 
growth, bone formation, vision, reproduction, maintenance of 
healthy epithelium, and optimal immune function. Sections II 
and III describe experiments which evaluated effects of 
administration of 13-cis-retinoic acid, a derivative of 
vitamin A, on plasma vitamin concentrations and immune 
function in normal dairy cattle. In Section II, alterations 
in plasma vitamin concentrations and mitogen-induced 
lymphocyte blastogenesis assays were examined. Plasma 
concentrations of 13-cis-, all-trans-, and 9-cis-retinoic acid 
were significantly elevated in cattle receiving 13-cis-
retinoic acid. Therefore, 13-cis-retinoic acid administration 
to cattle is an effective method for alteration of plasma 
concentrations of retinoic acid isomers and may provide a 
valuable means of studying vitamin A status in cattle. Plasma 
concentrations of retinol, fi-carotene, and a-tocopherol more 
than adequate before the study began and throughout the study. 
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Concentrations of retinol, 6-carotene, and o-tocopherol were 
not affected by administration of 13-cis-retinoic acid. 
Blastogenic response to 2 different mitogens was not 
affected by 13-cis-retinoic acid administration to cattle, 
however, supplementation of PWM-stimulated HNL from control 
and 13-cis-retinoic acid treated animals with 13-cis-retinoic 
acid inhibited, but did not abrogate, lymphocyte 
blastogenesis. Therefore, administration of 13-cis-retinoic 
acid alters plasma concentrations of retinoic acid isomers and 
modulates function of MNL in vitro without affecting plasma 
concentrations of retinol, fi-carotene, or a-tocopherol. 
In Section III, effects of 13-cis-retinoic acid 
administration to cattle on serum Ig concentrations, PWM-
Induced IgM production in vitro, total blood leukocyte counts, 
and phenotype of peripheral blood leukocytes were examined. 
Serum IgG was significantly increased in cattle receiving the 
greatest dose of 13-cis-retinoic acid compared to untreated 
cattle. Serum IgM tended to follow the same trend as serum 
IgG. Administration of 13-cis-retinoic acid to cattle did not 
affect PWM-stimulated IgM production although addition of 13-
cis-retinoic acid to cultures of pokeweed-mitogen stimulated 
leukocytes increased IgM production. Total blood leukocyte 
counts were not affected by 13-cis-retinoic acid 
administration to cattle. Flow cytometric analysis of 
peripheral blood leukocytes revealed a significant increase in 
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numbers of circulating B-cells in cattle receiving 200 mg 13-
cis-retinoic acid per d. Results suggest 13-cis-retinoic acid 
may modulate immune function of dairy cattle through effects 
on B-cells. Results from Section I indicate PWM stimulates 
increased IgM production indirectly through its effects on T-
helper cells. Results from Section II, however, indicate that 
in vitro addition of 13-cis-retinoic acid to cultures of 
bovine mononuclear leukocytes inhibited mitogen-stimulated 
proliferation. Therefore, increased IgM production in vitro, 
as a result of addition of 13-cis-retinoic acid to cultures, 
is likely a result of differentiation (with less 
proliferation) of T-helper cells into effector cells that 
secrete cytokines affecting B-cell function. Increased 
concentrations of IgG in serum also may be a consequence of T-
helper cell activation or differentiation in vivo by 
administration of 13-cis-retinoic acid. Determination of 
types and quantities of cytokines produced as a result of 13-
cis-retinoic acid administration to cattle would provide 
important information regarding the mechanism of action of 13-
cis-retinoic acid on T-helper cells, resulting in production 
of cytokines that might impact B-cell function. 
Studies presented in Sections II and III indicate 13-cis-
retinoic acid administration to dairy cattle modulates immune 
function, although effects were minor. Cattle in the present 
study had more than adequate concentrations of retinol and 13-
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carotene which may account in part for the lack of effect of 
13-cis-retinoic acid administration on immune function. Dairy 
cattle are immunosuppressed and often have a marginal vitamin 
A status at parturition. Therefore, administration of 13-cis-
retinoic acid should be investigated as a means of decreasing 
the incidence of mastitis in dairy cows in the periparturient 
period, a time when vitamin A status may be low. Doses of 13-
cis-retinoic acid used in the present study were lower than 
doses administered to humans or mice. Future studies should 
investigate effects of administration of larger doses of 13-
cis-retinoic acid to cattle. 
Murine and human studies found significantly enhanced 
responses to antigens in conjunction with administration of 
13-cis-retlnoic acid. Antigenic responsiveness may be a more 
sensitive means of determining the degree of Immunomodulation 
achieved through administration of 13-cls-retlnolc acid and 
should be investigated in cattle. 
» 
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